| Sephora | 87.5 | 2 | 7 |
| Credo | 68.7 | 2 | 2 |
| L'Occitane en Provence | 61.0 | 1 | 4 |
| Birchbox | 60.9 | 2 | 1 |
| New York | 60.0 | 3 | 0 |
| Vogue | 47.5 | 2 | 0 |
| Marie Claire | 47.5 | 2 | 0 |
| Net-a-Porter | 47.5 | 2 | 0 |
| Yoox Net-a-Porter Group | 47.5 | 2 | 0 |
| Business Mirror | 47.5 | 2 | 0 |
| PopSugar | 47.5 | 2 | 0 |
| Blue Apron | 47.5 | 2 | 0 |
| Raas International Clothing Inc | 47.5 | 2 | 0 |
| Fashionista | 47.5 | 2 | 0 |
| Aesop | 43.3 | 1 | 1 |
| Bluemercury | 43.3 | 1 | 1 |
| SkinCeuticals | 43.3 | 1 | 1 |
| Space NK | 43.3 | 1 | 1 |
| Ulta Beauty | 43.3 | 1 | 1 |
| Dermstore | 43.3 | 1 | 1 |
| Beauty Pie | 43.3 | 1 | 1 |
| ASOS | 31.0 | 0 | 4 |
| Barneys New York | 30.0 | 1 | 0 |
| Q79407 | 30.0 | 1 | 0 |
| Nordstrom | 30.0 | 1 | 0 |
| Bloomingdale's | 30.0 | 1 | 0 |
| Harrods | 30.0 | 1 | 0 |
| QVC | 30.0 | 1 | 0 |
| Us Weekly | 30.0 | 1 | 0 |
| Macy's | 30.0 | 1 | 0 |
| Neiman Marcus | 30.0 | 1 | 0 |
| Bergdorf Goodman | 30.0 | 1 | 0 |
| Environmental Working Group | 30.0 | 1 | 0 |
| The Financial Express | 30.0 | 1 | 0 |
| Selfridges | 30.0 | 1 | 0 |
| Douglas Holding | 30.0 | 1 | 0 |
| Saks Fifth Avenue | 30.0 | 1 | 0 |
| Harvey Nichols | 30.0 | 1 | 0 |
| Liberty | 30.0 | 1 | 0 |
| AAIA – Automotive Aftermarket Industry Association | 30.0 | 1 | 0 |
| Boutique La Vie en rose | 30.0 | 1 | 0 |
| Famous-Barr | 30.0 | 1 | 0 |
| Harbour City | 30.0 | 1 | 0 |
| Caudalie | 30.0 | 1 | 0 |
| Manila Standard | 30.0 | 1 | 0 |
| Who, What, Wear | 30.0 | 1 | 0 |
| Similarweb | 30.0 | 1 | 0 |
| La Roche-Posay | 21.1 | 0 | 2 |
| cleanser | 21.1 | 0 | 2 |
| American Journal of Clinical Oncology | 21.1 | 0 | 2 |
| No7 product line | 21.1 | 0 | 2 |
| Key design considerations on comparative clinical efficacy studies for biosimilars: adalimumab as an example | 21.1 | 0 | 2 |
| Cancer clinical trials | 21.1 | 0 | 2 |
| Skin rejuvenation using cosmetic products containing growth factors, cytokines, and matrikines: a review of the literature | 21.1 | 0 | 2 |
| Clinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia. The Azithromycin Intravenous Clinical Trials Group | 21.1 | 0 | 2 |
| Clinical Efficacy and Tolerability of Praziquantel for Intestinal and Urinary Schistosomiasis—A Meta-analysis of Comparative and Non-comparative Clinical Trials | 21.1 | 0 | 2 |
| The Schistosomiasis Clinical Trials Landscape: A Systematic Review of Antischistosomal Treatment Efficacy Studies and a Case for Sharing Individual Participant-Level Data (IPD) | 21.1 | 0 | 2 |
| Clinical Efficacy and Tolerability of Sumatriptan Tablet and Suppository in the Acute Treatment of Migraine: A Review of Data from Clinical Trials | 21.1 | 0 | 2 |
| Evidence of clinical efficacy of homeopathy. A meta-analysis of clinical trials. HMRAG. Homeopathic Medicines Research Advisory Group | 21.1 | 0 | 2 |
| First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 4: pre-clinical efficacy and complication data required to just | 21.1 | 0 | 2 |
| Interleukin-6 inhibition and clinical efficacy in rheumatoid arthritis treatment--data from randomized clinical trials. | 21.1 | 0 | 2 |
| Exposure data for cosmetic products: facial cleanser, hair conditioner, and eye shadow | 21.1 | 0 | 2 |
| Clinical trials with haemopoietic growth factors | 21.1 | 0 | 2 |
| The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 4: Pre-clinical efficacy and complication data required to justify a clinical t | 21.1 | 0 | 2 |
| Assessment of the clinical efficacy of a hyaluronic acid-based deep wrinkle filler using new instrumental methods | 21.1 | 0 | 2 |
| Relationships of growth factors, proinflammatory cytokines, and anti-inflammatory cytokines with long-term clinical results of autologous bone marrow mononuclear cell transplantation in STEMI | 21.1 | 0 | 2 |
| Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting | 21.1 | 0 | 2 |
| Clinical efficacy of a spray containing hyaluronic Acid and dexpanthenol after surgery in the nasal cavity (septoplasty, simple ethmoid sinus surgery, and turbinate surgery) | 21.1 | 0 | 2 |
| Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies | 21.1 | 0 | 2 |
| Review of Preclinical and Clinical Results with Vascular Endothelial Growth Factors for Therapeutic Angiogenesis. | 21.1 | 0 | 2 |
| Maintenance of clinical efficacy after dose reduction of ixabepilone plus capecitabine in patients with anthracycline- and taxane-resistant metastatic breast cancer: a retrospective analysis of pooled data from 2 phase III randomized clinical trials | 21.1 | 0 | 2 |
| Clinical efficacy of spironolactone for resistant hypertension: a meta analysis from randomized controlled clinical trials | 21.1 | 0 | 2 |
| Translating research to promote healthy aging: the complementary role of longitudinal studies and clinical trials | 21.1 | 0 | 2 |
| Improvement in skin wrinkles using a preparation containing human growth factors and hyaluronic acid serum | 21.1 | 0 | 2 |
| Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis | 21.1 | 0 | 2 |
| Clinical trials of myeloid growth factors | 21.1 | 0 | 2 |
| Healthy aging: can clinical trials deliver? | 21.1 | 0 | 2 |
| Clinical efficacy of intra-articular injections in knee osteoarthritis: a prospective randomized study comparing hyaluronic acid and betamethasone | 21.1 | 0 | 2 |
| Hematopoietic growth factors: a summary of their biology in tissue culture, animals, and clinical trials | 21.1 | 0 | 2 |
| Systematic Review of Clinical Trials of Small- and Large-Gel-Particle Hyaluronic Acid Injectable Fillers for Aesthetic Soft Tissue Augmentation | 21.1 | 0 | 2 |
| Clinical efficacy of growth factors to enhance tissue repair in oral and maxillofacial reconstruction: a systematic review | 21.1 | 0 | 2 |
| Clinical efficacy of second-generation tyrosine kinase inhibitors in imatinib-resistant gastrointestinal stromal tumors: a meta-analysis of recent clinical trials | 21.1 | 0 | 2 |
| Polyphenols as active ingredients for cosmetic products | 21.1 | 0 | 2 |
| Hyaluronic Acid Gel-Based Scaffolds as Potential Carrier for Growth Factors: An In Vitro Bioassay on Its Osteogenic Potential. | 21.1 | 0 | 2 |
| Effects of hyaluronic acid combined with anti-inflammatory drugs compared with hyaluronic acid alone, in clinical trials and experiments in osteoarthritis: a systematic review and meta-analysis. | 21.1 | 0 | 2 |
| Will a single periarticular lidocaine–corticosteroid injection improve the clinical efficacy of intraarticular hyaluronic acid treatment of symptomatic knee osteoarthritis? | 21.1 | 0 | 2 |
| Trimodal rescue of hind limb ischemia with growth factors, cells, and nanocarriers: fundamentals to clinical trials | 21.1 | 0 | 2 |
| Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease | 21.1 | 0 | 2 |
| Treatment of knee osteoarthritis: platelet-derived growth factors vs. hyaluronic acid. A randomized controlled trial | 21.1 | 0 | 2 |
| Diclofenac/misoprostol. A review of the major clinical trials evaluating its clinical efficacy and upper gastrointestinal tolerability in rheumatoid arthritis and osteoarthritis. | 21.1 | 0 | 2 |
| Hematopoietic growth factors after allogeneic marrow transplantation in animal studies and clinical trials. | 21.1 | 0 | 2 |
| A review of calculus clinical efficacy studies. | 21.1 | 0 | 2 |
| Hematopoietic growth factors and chemoprotectants: should we move toward a two-step process for phase I clinical trials in oncology? | 21.1 | 0 | 2 |
| A review of plaque, gingivitis, calculus and caries clinical efficacy studies with a dentifrice containing triclosan and PVM/MA Copolymer. | 21.1 | 0 | 2 |
| A review of plaque, gingivitis, calculus and caries clinical efficacy studies with a fluoride dentifrice containing triclosan and PVM/MA copolymer | 21.1 | 0 | 2 |
| Changes in synovial fluid biomarkers and clinical efficacy of intra‐articular injections of hyaluronic acid for patients with knee osteoarthritis | 21.1 | 0 | 2 |
| Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients | 21.1 | 0 | 2 |
| Should your algorithm include plasma rich in growth factors in the light of its clinical efficacy and safety?: By Vaquerizo V. et al. | 21.1 | 0 | 2 |
| Aging skin is functionally anaerobic: importance of coenzyme Q10 for anti aging skin care | 21.1 | 0 | 2 |
| Dry powder inhaled compound delivery for early pre-clinical in vivo efficacy studies | 21.1 | 0 | 2 |
| Growth factors expression in hyaluronic acid fat graft myringoplasty | 21.1 | 0 | 2 |
| Biocompounds from rapeseed oil industry co-stream as active ingredients for skin care applications | 21.1 | 0 | 2 |
| Quality of life in postmenopausal women: translation and validation of MSkinQOL questionnaire to measure the effect of a skincare product in USA | 21.1 | 0 | 2 |
| Biochemical and aerosol characterization of ricin for use in non-clinical efficacy studies. | 21.1 | 0 | 2 |
| Clinical Evaluation of a Multi-Modal Facial Serum That Addresses Hyaluronic Acid Levels in Skin | 21.1 | 0 | 2 |
| Hyaluronic acid-based hydrogel scaffold without angiogenic growth factors enhances ovarian tissue function after autotransplantation in rats | 21.1 | 0 | 2 |
| Growth factors for diabetic foot ulcers: mixed treatment comparison analysis of randomized clinical trials. | 21.1 | 0 | 2 |
| The effect of oral collagen peptide supplementation on skin moisture and the dermal collagen network: evidence from an ex vivo model and randomized, placebo‐controlled clinical trials | 21.1 | 0 | 2 |
| Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Endoret) versus Durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: a randomized controlled trial. | 21.1 | 0 | 2 |
| A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. | 21.1 | 0 | 2 |
| Should your algorithm include plasma rich in growth factors in the light of its clinical efficacy and safety? | 21.1 | 0 | 2 |
| Growth factors-loaded stents modified with hyaluronic acid and heparin for induction of rapid and tight re-endothelialization. | 21.1 | 0 | 2 |
| Novel eye cream containing a mixture of human growth factors and cytokines for periorbital skin rejuvenation | 21.1 | 0 | 2 |
| Preparation and in vivo evaluation of cationic elastic liposomes comprising highly skin-permeable growth factors combined with hyaluronic acid for enhanced diabetic wound-healing therapy | 21.1 | 0 | 2 |
| Experimental and Clinical Efficacy of Two Hyaluronic Acid-based Compounds of Different Cross-Linkage and Composition in the Rejuvenation of the Skin | 21.1 | 0 | 2 |
| Hyaluronic acid induces the release of growth factors from platelet-rich plasma | 21.1 | 0 | 2 |
| In response to Growth factors expression in hyaluronic acid fat graft myringoplasty | 21.1 | 0 | 2 |
| Clinical Efficacy Studies of Haloprogin, a New Topical Antimicrobial Agent | 21.1 | 0 | 2 |
| An ex vivo biochemical model to study the antioxidant clinical properties of cosmetic products in human antiaging skin care | 21.1 | 0 | 2 |
| Production and characterization of hyaluronic acid microparticles for the controlled delivery of growth factors using a spray/dehydration method | 21.1 | 0 | 2 |
| Hyaluronic Acid, PRP/Growth Factors, and Stem Cells in the Treatment of Osteochondral Lesions | 21.1 | 0 | 2 |
| Clinical Efficacy and Safety in Children with Vesicoureteral Reflux of a Single Injection of Two Different Bulking Agents – Polydimethylsiloxane (Macroplastique) or Dextranomer/Hyaluronic Acid Copolymer (Deflux): A Short-Term Prospective Comparativ | 21.1 | 0 | 2 |
| Sunscreen and facial skin care products in frontal fibrosing alopecia: a case control study | 21.1 | 0 | 2 |
| Developing standard procedures for pre-clinical efficacy studies in mouse models of spinal muscular atrophy | 21.1 | 0 | 2 |
| Intraarticular Glucose Versus Hyaluronic Acid Injection for Knee Osteoarthrosis | 21.1 | 0 | 2 |
| Assessment of the Efficacy and Barrier Protection of Two Cosmetic Products | 21.1 | 0 | 2 |
| Hyaluronic Acid Combined with Serum Rich in Growth Factors in Corneal Epithelial Defects | 21.1 | 0 | 2 |
| Diagnostic pertussis serology in the recent clinical efficacy studies of acellular vaccines | 21.1 | 0 | 2 |
| Periodontal Wound Healing With CHX and Hyaluronic Acid | 21.1 | 0 | 2 |
| What is the Best Degree of Hyaluronic Acid Crosslinking in Increasing Growth Factors Level of Platelet-Rich Fibrin Lysate? | 21.1 | 0 | 2 |
| Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D Treatment | 21.1 | 0 | 2 |
| A Pooled Analysis of the Data From Two Studies of Ammonium Succinate for Menopausal Symptoms | 21.1 | 0 | 2 |
| Treatment of Knee Arthrosis With Platelet-derived Growth Factors vs. Hyaluronic Acid. | 21.1 | 0 | 2 |
| Increasing the scientific quality of clinical efficacy studies of magnetic resonance imaging | 21.1 | 0 | 2 |
| Human recombinant hemopoietic growth factors G-CSF and GM-CSF: first results of clinical trials | 21.1 | 0 | 2 |
| Growth factors, act II: movement into and through clinical trials | 21.1 | 0 | 2 |
| Symposium on comparison of clinical efficacy among various kinds of chemotherapeutic regimens for pulmonary tuberculosis. 3. Methodology of clinical trials | 21.1 | 0 | 2 |
| Local action of hyaluronic acid on reparative processes of the connective tissue. Clinical results | 21.1 | 0 | 2 |
| Prevention of postoperative pericardial adhesions with a hyaluronic acid coating solution. Experimental safety and efficacy studies | 21.1 | 0 | 2 |
| Cytokeratin expression and hyaluronic acid production in cultures of human synovial microvascular endothelial cells: influence of cytokines and growth factors | 21.1 | 0 | 2 |
| Clinical efficacy and safety of tazarotene: optimizing clinical results | 21.1 | 0 | 2 |
| Proteolytic inactivation of transforming growth factor beta3 by elastase in venous leg ulcers: implications for clinical trials using topically-applied peptide growth factors | 21.1 | 0 | 2 |
| [Methodological thoughts on clinical efficacy evaluation with multiple clinical trials] | 21.1 | 0 | 2 |
| Clinical trials in metastatic hormone-refractory prostate cancer: improving docetaxel therapy by targeting bone-related growth factors | 21.1 | 0 | 2 |
| Making repeated clinical trials aiming at finding specific indications is the way for improving clinical efficacy of traditional Chinese medicine | 21.1 | 0 | 2 |
| Multicenter study of hyaluronic acid obtained by biotechnology to evaluate clinical efficacy and safety in knee osteoarthritis | 21.1 | 0 | 2 |
| Clinical grade cultivation of human Schwann cell, by the using of human autologous serum instead of fetal bovine serum and without growth factors | 21.1 | 0 | 2 |
| Definition of clinical efficacy and safety outcomes for clinical trials in deep venous thrombosis and pulmonary embolism in children | 21.1 | 0 | 2 |
| Clinical efficacy and randomized clinical trials in dysphagia | 21.1 | 0 | 2 |
| Plasma rich in growth factors (PRGF-Endoret) stimulates tendon and synovial fibroblasts migration and improves the biological properties of hyaluronic acid | 21.1 | 0 | 2 |
| Acute antibiotic use in cystic fibrosis clinical trials: does it affect our assessment of clinical efficacy? | 21.1 | 0 | 2 |
| Effects of washing of the face with a mild facial cleanser formulated with sodium laureth carboxylate and alkyl carboxylates on acne in Japanese adult males | 21.1 | 0 | 2 |
| Efficacy and Safety of Hyaluronic Acid Gel for the Prevention of Intrauterine Adhesion: A Meta-Analysis of Randomized Clinical Trials | 21.1 | 0 | 2 |
| In Reference to Growth factors expression in hyaluronic acid fat graft myringoplasty | 21.1 | 0 | 2 |
| Comparison of intra-articular injection of plasma rich in growth factors versus hyaluronic acid following arthroscopy in the treatment of temporomandibular dysfunction: A randomised prospective study | 21.1 | 0 | 2 |
| Prospective trial for the clinical efficacy of anogenital skin care with miconazole nitrate-containing soap for diaper candidiasis | 21.1 | 0 | 2 |
| Preservation techniques of stem cells extracellular vesicles: a gate for manufacturing of clinical grade therapeutic extracellular vesicles and long-term clinical trials | 21.1 | 0 | 2 |
| Clinical efficacy of platelet-rich plasma in the treatment of lateral epicondylitis: a systematic review and meta-analysis of randomized placebo-controlled clinical trials | 21.1 | 0 | 2 |
| The Clinical Efficacy of Pulmonary Hypertension-Specific Agents in Idiopathic Pulmonary Fibrosis: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials | 21.1 | 0 | 2 |
| Statistical Considerations on Clinical Efficacy Studies of Biosimilar for PMDA Submission | 21.1 | 0 | 2 |
| Natural Does Not Mean Safe-The Dirt on Clean Beauty Products | 21.1 | 0 | 2 |
| Injectable and tunable hyaluronic acid hydrogels releasing chemotactic and angiogenic growth factors for endodontic regeneration | 21.1 | 0 | 2 |
| Clinical efficacy of a chlorhexidine-based mouthrinse containing hyaluronic acid and an antidiscoloration system in patients undergoing flap surgery: A triple-blind, parallel-arm, randomized controlled trial | 21.1 | 0 | 2 |
| Commentary on JAMA Dermatology Editorial: "Natural Does Not Mean Safe-The Dirt on Clean Beauty Products" | 21.1 | 0 | 2 |
| Clinical Efficacy and Safety of Omalizumab in the Treatment of Allergic Rhinitis: A Systematic Review and Meta-analysis of Randomized Clinical Trials | 21.1 | 0 | 2 |
| Hyaluronic Acid as an Alternative to Autologous Human Serum Eye Drops: Initial Clinical Results with High-Molecular-Weight Hyaluronic Acid Eye Drops | 21.1 | 0 | 2 |
| Popular over-the-counter cosmeceutical ingredients and their clinical efficacy | 21.1 | 0 | 2 |
| Randomized masked trial of the clinical efficacy of MGO Manuka Honey microemulsion eye cream for the treatment of blepharitis | 21.1 | 0 | 2 |
| Clinical efficacy of a new cetylpyridinium chloride-hyaluronic acid-based mouthrinse compared to chlorhexidine and placebo mouthrinses-A 21-day randomized clinical trial | 21.1 | 0 | 2 |
| Demographics of Men and Minorities in Cosmetic Clinical Trials of Botulinum Toxin and Hyaluronic Acid Fillers | 21.1 | 0 | 2 |
| [Babaodan Capsules for viral hepatitis: systematic review of clinical efficacy and safety and Meta-analysis of randomized clinical trials] | 21.1 | 0 | 2 |
| Advances of hyaluronic acid in stem cell therapy and tissue engineering, including current clinical trials | 21.1 | 0 | 2 |
| Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials | 21.1 | 0 | 2 |
| Laboratory bioassay exploring the effects of anti-aging skincare products on free-living marine nematodes: a case study of collagen | 21.1 | 0 | 2 |
| PROMOTING HEALTHY AGING THROUGH PRAGMATIC CLINICAL TRIALS | 21.1 | 0 | 2 |
| Reply to Cosimo De Nunzio, Giacomo Novara, Rocco Damiano, Riccardo Bartoletti, Andrea Tubaro, and Vincenzo Ficarra's Letter to the Editor re: Giorgio Ivan Russo, Carmen Scandura, Marina Di Mauro, et al. Clinical Efficacy of Serenoa repens Versus Pla | 21.1 | 0 | 2 |
| Re: Giorgio Ivan Russo, Carmen Scandura, Marina Di Mauro, et al. Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network | 21.1 | 0 | 2 |
| beauty store | 21.1 | 0 | 2 |
| Hyaluronic Acid Filler in the Treatment for Drooping Tip: Anatomical Concepts and Clinical Results | 21.1 | 0 | 2 |
| A Randomized Study of Smile Exercise for Dry Eye | 21.1 | 0 | 2 |
| Effect of Active Ingredients of Chinese Herbal Medicine on the Rejuvenation of Healthy Aging: Focus on Stem Cells | 21.1 | 0 | 2 |
| Clinical efficacy of vitamin D supplementation on pulmonary TB patients: The evidence of clinical trials | 21.1 | 0 | 2 |
| Safety and Efficacy of a Novel Antiaging Skin Care Regimen Containing Neutraceuticals and Growth Factors on the Facial Skin of Women: A 12-Week Open-label Study | 21.1 | 0 | 2 |
| Clinical efficacy of ultrasound-guided hyaluronic acid injections in patients with supraspinatus tendon tear | 21.1 | 0 | 2 |
| Invited Discussion on: Hyaluronic Acid Filler in the Treatment of Drooping Tip-Anatomical Concepts and Clinical Results | 21.1 | 0 | 2 |
| Clinical efficacy and safety of secukinumab in patients with psoriasis and comorbidities: pooled analysis of 4 phase 3 clinical trials | 21.1 | 0 | 2 |
| Challenges and Effective Routes for Formulating and Delivery of Epidermal Growth Factors in Skin Care | 21.1 | 0 | 2 |
| The Clinical Efficacy And Safety Of SkinStylus Microneedling System | 21.1 | 0 | 2 |
| Evaluation of Clinical Efficacy of Different Injection Therapies for Treating Humeral Epicondylopathy | 21.1 | 0 | 2 |
| Peri-implantitis Surgical Regenerative Therapy Using Bovine Bone Substitute With Hyaluronic Acid | 21.1 | 0 | 2 |
| WATER'S EDGE DERMATOLOGY | 21.1 | 0 | 2 |
| Mecca | 21.1 | 0 | 2 |
| Clinical efficacy of zinc supplementation in improving antioxidant defense system: A comprehensive systematic review and time-response meta-analysis of controlled clinical trials | 21.1 | 0 | 2 |
| Clinical efficacy of diquafosol sodium 3% versus hyaluronic acid 0.1% in patients with dry eye disease after cataract surgery: a protocol for a single-centre, randomised controlled trial | 21.1 | 0 | 2 |
| A Study on the Beauty Action of the High-School Girl with the Beauty, Beauty Products, and Multi-function Beauty Product Interest | 21.1 | 0 | 2 |
| Luxury beauty products purchase behaviour of affluent consumers: the role of brand consciousness and brand distinctiveness in Zimbabwe | 21.1 | 0 | 2 |
| 587 Evaluating meaningful change in disease activity as a clinical efficacy measure for clinical trials in cutaneous lupus erythematosus | 21.1 | 0 | 2 |
| 556 Evaluating important change and clearance of disease activity as clinical efficacy measures for clinical trials in dermatomyositis | 21.1 | 0 | 2 |
| Clinical trials on the way to secure the translational and clinical efficacy | 21.1 | 0 | 2 |
| Hyaluronic Acid-Conjugated Thermoresponsive Polymer-Based Bioformulation Enhanced Wound Healing and Gut Barrier Repair of a TNBS-Induced Colitis Injury Ex Vivo Model in a Dynamic Perfusion Device | 21.1 | 0 | 2 |
| Influence of Brand Ambassador, Brand Awareness, and Price on Brand Image and Purchasing Decision in Halal Skincare Product (Study on MS Glow Skincare Products in Surabaya) | 21.1 | 0 | 2 |
| Konga Health | 21.1 | 0 | 2 |
| Beautinow | 21.1 | 0 | 2 |
| vascular endothelial growth factor | 13.3 | 0 | 1 |
| clinical trial | 13.3 | 0 | 1 |
| classical genetics | 13.3 | 0 | 1 |
| cosmetics | 13.3 | 0 | 1 |
| Rita Levi-Montalcini | 13.3 | 0 | 1 |
| Anatomical Therapeutic Chemical Classification System | 13.3 | 0 | 1 |
| Roger Y. Tsien | 13.3 | 0 | 1 |
| Stanley Cohen | 13.3 | 0 | 1 |
| Clearasil | 13.3 | 0 | 1 |
| hyaluronic acid | 13.3 | 0 | 1 |
| growth factor | 13.3 | 0 | 1 |
| nerve growth factor | 13.3 | 0 | 1 |
| transforming growth factor | 13.3 | 0 | 1 |
| translational medical research | 13.3 | 0 | 1 |
| life extension | 13.3 | 0 | 1 |
| Weleda | 13.3 | 0 | 1 |
| toner | 13.3 | 0 | 1 |
| Calgon | 13.3 | 0 | 1 |
| BIPA | 13.3 | 0 | 1 |
| Cosmopolitan Cosmetics | 13.3 | 0 | 1 |
| pit bull | 13.3 | 0 | 1 |
| beauty salon | 13.3 | 0 | 1 |
| Donald Metcalf | 13.3 | 0 | 1 |
| EudraCT | 13.3 | 0 | 1 |
| skin care | 13.3 | 0 | 1 |
| vaporizer | 13.3 | 0 | 1 |
| Revlon | 13.3 | 0 | 1 |
| hematopoietic growth factor | 13.3 | 0 | 1 |
| Good Clinical Practice | 13.3 | 0 | 1 |
| Import Parfumerie | 13.3 | 0 | 1 |
| natural cosmetics | 13.3 | 0 | 1 |
| clinical trials registry | 13.3 | 0 | 1 |
| Clinical Trials Directive | 13.3 | 0 | 1 |
| Cosmetics Directive | 13.3 | 0 | 1 |
| Neutrogena | 13.3 | 0 | 1 |
| Biotherm | 13.3 | 0 | 1 |
| efficacy | 13.3 | 0 | 1 |
| kangaroo care | 13.3 | 0 | 1 |
| Make-up Art Cosmetics | 13.3 | 0 | 1 |
| medical research | 13.3 | 0 | 1 |
| Artistry | 13.3 | 0 | 1 |
| data monitoring committee | 13.3 | 0 | 1 |
| Consolidated Standards of Reporting Trials | 13.3 | 0 | 1 |
| Natura Cosméticos S.A. | 13.3 | 0 | 1 |
| Hyaluronan sodium | 13.3 | 0 | 1 |
| ISIPCA | 13.3 | 0 | 1 |
| Iris Pharma | 13.3 | 0 | 1 |
| Keosys | 13.3 | 0 | 1 |
| transdermal administration | 13.3 | 0 | 1 |
| STEP Study | 13.3 | 0 | 1 |
| Kiko Milano | 13.3 | 0 | 1 |
| NARS Cosmetics | 13.3 | 0 | 1 |
| Q4044353 | 13.3 | 0 | 1 |
| AIDS Clinical Trials Group | 13.3 | 0 | 1 |
| Academic clinical trials | 13.3 | 0 | 1 |
| Alliance for Clinical Trials in Oncology | 13.3 | 0 | 1 |
| analysis of clinical trials | 13.3 | 0 | 1 |
| Aquaphor | 13.3 | 0 | 1 |
| Augusta FireBall | 13.3 | 0 | 1 |
| Aveeno | 13.3 | 0 | 1 |
| Bronner Bros. | 13.3 | 0 | 1 |
| CSUCT | 13.3 | 0 | 1 |
| Cetaphil | 13.3 | 0 | 1 |
| Children's Oncology Group | 13.3 | 0 | 1 |
| Clarisonic | 13.3 | 0 | 1 |
| ClinicalTrials.gov | 13.3 | 0 | 1 |
| Clinical Trials | 13.3 | 0 | 1 |
| Clinical trials publication | 13.3 | 0 | 1 |
| Clinical trials unit | 13.3 | 0 | 1 |
| Conair Corporation | 13.3 | 0 | 1 |
| Contemporary Clinical Trials | 13.3 | 0 | 1 |
| Controlled clinical trials | 13.3 | 0 | 1 |
| Cosmetics advertising | 13.3 | 0 | 1 |
| Data confidentiality in clinical trials | 13.3 | 0 | 1 |
| anti-aging cream | 13.3 | 0 | 1 |
| Ella Baché | 13.3 | 0 | 1 |
| End point of clinical trials | 13.3 | 0 | 1 |
| Ethical problems using children in clinical trials | 13.3 | 0 | 1 |
| European and Developing Countries Clinical Trials Partnership | 13.3 | 0 | 1 |
| FGF15/19 | 13.3 | 0 | 1 |
| phase I clinical trial | 13.3 | 0 | 1 |
| Freederm | 13.3 | 0 | 1 |
| Gerovital | 13.3 | 0 | 1 |
| Glasgow Clinical Trials Unit | 13.3 | 0 | 1 |
| Gold Bond | 13.3 | 0 | 1 |
| Growth Factors Journal | 13.3 | 0 | 1 |
| Gurwitch Products | 13.3 | 0 | 1 |
| H5N1 clinical trials | 13.3 | 0 | 1 |
| Human embryonic stem cells clinical trial | 13.3 | 0 | 1 |
| IFPMA Clinical Trials Portal | 13.3 | 0 | 1 |
| International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 13.3 | 0 | 1 |
| MEDIDATA Solutions | 13.3 | 0 | 1 |
| Minimisation | 13.3 | 0 | 1 |
| monitoring in clinical trials | 13.3 | 0 | 1 |
| Natural skin care | 13.3 | 0 | 1 |
| New Clicks Holdings Limited | 13.3 | 0 | 1 |
| Category:Clinical trials | 13.3 | 0 | 1 |
| North Central Cancer Treatment Group | 13.3 | 0 | 1 |
| oncophage | 13.3 | 0 | 1 |
| Oxytrex | 13.3 | 0 | 1 |
| PLOS Clinical Trials | 13.3 | 0 | 1 |
| patient-reported outcome | 13.3 | 0 | 1 |
| Pond's Creams | 13.3 | 0 | 1 |
| Prestige Brands | 13.3 | 0 | 1 |
| Priceline | 13.3 | 0 | 1 |
| rating | 13.3 | 0 | 1 |
| Response-rate ratio | 13.3 | 0 | 1 |
| Category:Skin care | 13.3 | 0 | 1 |
| Stratify | 13.3 | 0 | 1 |
| Superdrug | 13.3 | 0 | 1 |
| Trade Secrets | 13.3 | 0 | 1 |
| neurotrophic receptor tyrosine kinase 2 | 13.3 | 0 | 1 |
| Vie at Home | 13.3 | 0 | 1 |
| Category:Clinical trials related to HIV | 13.3 | 0 | 1 |
| Category:Growth factors | 13.3 | 0 | 1 |
| Category:Prestige Brands brands | 13.3 | 0 | 1 |
| Kicks | 13.3 | 0 | 1 |
| OXY | 13.3 | 0 | 1 |
| Hoai Chemical | 13.3 | 0 | 1 |
| bath additive | 13.3 | 0 | 1 |
| Hada Labo | 13.3 | 0 | 1 |
| Cidesco | 13.3 | 0 | 1 |
| Template:Growth factors | 13.3 | 0 | 1 |
| viscosupplementation | 13.3 | 0 | 1 |
| baby oil | 13.3 | 0 | 1 |
| cosmetics industry | 13.3 | 0 | 1 |
| Category:Prestige Brands | 13.3 | 0 | 1 |
| Mannings | 13.3 | 0 | 1 |
| growth factor activity | 13.3 | 0 | 1 |
| keratinocyte activation | 13.3 | 0 | 1 |
| NGF | 13.3 | 0 | 1 |
| TOR signaling | 13.3 | 0 | 1 |
| hyaluronic acid binding | 13.3 | 0 | 1 |
| glycosaminoglycan metabolic process | 13.3 | 0 | 1 |
| hyaluronan metabolic process | 13.3 | 0 | 1 |
| hyaluronan catabolic process | 13.3 | 0 | 1 |
| neurotrophin binding | 13.3 | 0 | 1 |
| neurotrophin receptor activity | 13.3 | 0 | 1 |
| Neurotrophic tyrosine kinase, receptor, type 2 | 13.3 | 0 | 1 |
| hyaluronan biosynthetic process | 13.3 | 0 | 1 |
| Category:Clinical trials by sponsor | 13.3 | 0 | 1 |
| Category:Clinical trials by type | 13.3 | 0 | 1 |
| Category:Clinical trials sponsored by AstraZeneca | 13.3 | 0 | 1 |
| Category:Clinical trials sponsored by NIAID | 13.3 | 0 | 1 |
| Category:Clinical trials related to cancer | 13.3 | 0 | 1 |
| Applied Clinical Trials: your peer-reviewed guide to global clinical trials management | 13.3 | 0 | 1 |
| HIV Clinical Trials | 13.3 | 0 | 1 |
| Clinical Trials Insight Classics Pharmacoeconomics | 13.3 | 0 | 1 |
| Open Access Journal of Clinical Trials | 13.3 | 0 | 1 |
| Pechoin | 13.3 | 0 | 1 |
| YSL Beauty | 13.3 | 0 | 1 |
| adaptive clinical trial | 13.3 | 0 | 1 |
| KORA Organics | 13.3 | 0 | 1 |
| angiocrine growth factors | 13.3 | 0 | 1 |
| Premier Dead Sea | 13.3 | 0 | 1 |
| Semichem | 13.3 | 0 | 1 |
| Clinical trials on glucosamine and chondroitin | 13.3 | 0 | 1 |
| Nardo's Natural | 13.3 | 0 | 1 |
| Rachel K | 13.3 | 0 | 1 |
| patient selection | 13.3 | 0 | 1 |
| Informed assent | 13.3 | 0 | 1 |
| Independent clinical trials | 13.3 | 0 | 1 |
| Johnson's Baby | 13.3 | 0 | 1 |
| Habp4 | 13.3 | 0 | 1 |
| Habp2 | 13.3 | 0 | 1 |
| Gm7770 | 13.3 | 0 | 1 |
| Gm3318 | 13.3 | 0 | 1 |
| My Beauty Diary | 13.3 | 0 | 1 |
| Zoe Foster Blake | 13.3 | 0 | 1 |
| Clinical Efficacy of Blue Light Full Body Irradiation as Treatment Option for Severe Atopic Dermatitis | 13.3 | 0 | 1 |
| The clinical efficacy of artemether/lumefantrine (Coartem) | 13.3 | 0 | 1 |
| Skin care | 13.3 | 0 | 1 |
| Vitamin D supplementation and breast cancer prevention: a systematic review and meta-analysis of randomized clinical trials | 13.3 | 0 | 1 |
| The forgotten role of alcohol: a systematic review and meta-analysis of the clinical efficacy and perceived role of chlorhexidine in skin antisepsis | 13.3 | 0 | 1 |
| Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials | 13.3 | 0 | 1 |
| finerenone | 13.3 | 0 | 1 |
| Hyaluronan binding protein 2 | 13.3 | 0 | 1 |
| neuregulin receptor activity | 13.3 | 0 | 1 |
| Lymphatic vessel endothelial hyaluronan receptor 1 | 13.3 | 0 | 1 |
| Stabilin 2 | 13.3 | 0 | 1 |
| Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 × 106/l | 13.3 | 0 | 1 |
| Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials | 13.3 | 0 | 1 |
| Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials | 13.3 | 0 | 1 |
| The effect of ginseng (the genus panax) on glycemic control: a systematic review and meta-analysis of randomized controlled clinical trials | 13.3 | 0 | 1 |
| Hyaluronan synthase 1 | 13.3 | 0 | 1 |
| Hyaluronan synthase 2 | 13.3 | 0 | 1 |
| Hyaluronan mediated motility receptor | 13.3 | 0 | 1 |
| Insulin-Like Growth Factors Promote Vasculogenesis in Embryonic Stem Cells | 13.3 | 0 | 1 |
| Smoking, Green Tea Consumption, Genetic Polymorphisms in the Insulin-Like Growth Factors and Lung Cancer Risk | 13.3 | 0 | 1 |
| Hyaluronan synthase 3 | 13.3 | 0 | 1 |
| Clinical trials and medical care: defining the therapeutic misconception | 13.3 | 0 | 1 |
| positive regulation of growth factor dependent skeletal muscle satellite cell proliferation | 13.3 | 0 | 1 |
| growth factor dependent regulation of skeletal muscle satellite cell proliferation | 13.3 | 0 | 1 |
| Clinical trials in severe sepsis with drotrecogin alfa (activated) | 13.3 | 0 | 1 |
| Tyrosine kinase signalling in breast cancer: insulin-like growth factors and their receptors in breast cancer. | 13.3 | 0 | 1 |
| What should be the core outcomes in chronic pain clinical trials? | 13.3 | 0 | 1 |
| Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents | 13.3 | 0 | 1 |
| The roles of platelet-derived growth factors and their receptors in brain radiation necrosis | 13.3 | 0 | 1 |
| Likely country of origin in publications on randomised controlled trials and controlled clinical trials during the last 60 years | 13.3 | 0 | 1 |
| Standard requirements for GCP-compliant data management in multinational clinical trials | 13.3 | 0 | 1 |
| Evidence for placebo effects on physical but not on biochemical outcome parameters: a review of clinical trials | 13.3 | 0 | 1 |
| ASCOT: a text mining-based web-service for efficient search and assisted creation of clinical trials | 13.3 | 0 | 1 |
| Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials | 13.3 | 0 | 1 |
| Ukrain - a new cancer cure? A systematic review of randomised clinical trials | 13.3 | 0 | 1 |
| Glucosamine for osteoarthritis: biological effects, clinical efficacy, and safety on glucose metabolism | 13.3 | 0 | 1 |
| The Use of Garcinia Extract (Hydroxycitric Acid) as a Weight loss Supplement: A Systematic Review and Meta-Analysis of Randomised Clinical Trials | 13.3 | 0 | 1 |
| The use of green coffee extract as a weight loss supplement: a systematic review and meta-analysis of randomised clinical trials | 13.3 | 0 | 1 |
| Lymphatic vessel endothelial hyaluronan receptor 1 | 13.3 | 0 | 1 |
| Hyaluronic acid binding protein 2 | 13.3 | 0 | 1 |
| Hyaluronic acid binding protein 4 | 13.3 | 0 | 1 |
| Linking ClinicalTrials.gov and PubMed to track results of interventional human clinical trials | 13.3 | 0 | 1 |
| Synergistic and additive effects of hydrostatic pressure and growth factors on tissue formation | 13.3 | 0 | 1 |
| Publication of clinical trials supporting successful new drug applications: a literature analysis | 13.3 | 0 | 1 |
| WikiProject Clinical Trials | 13.3 | 0 | 1 |
| Hyaluronan mediated motility receptor (RHAMM) | 13.3 | 0 | 1 |
| Hyaluronan synthase 3 | 13.3 | 0 | 1 |
| Hyaluronan synthase 2 | 13.3 | 0 | 1 |
| Hyaluronan synthase 1 | 13.3 | 0 | 1 |
| The effects of angiogenic growth factors on extravillous trophoblast invasion and motility | 13.3 | 0 | 1 |
| Sulfonylurea versus metformin monotherapy in patients with type 2 diabetes: a Cochrane systematic review and meta-analysis of randomized clinical trials and trial sequential analysis | 13.3 | 0 | 1 |
| Defining the clinical course of multiple sclerosis: Results of an international survey | 13.3 | 0 | 1 |
| Long-term follow-up of clinical trials of multiple sclerosis therapies | 13.3 | 0 | 1 |
| A systematic review of randomized, double-blind, placebo-controlled trials examining the clinical efficacy of vitamin D in multiple sclerosis | 13.3 | 0 | 1 |
| neuregulin binding | 13.3 | 0 | 1 |
| Methodological aspects of clinical trials in tinnitus: a proposal for an international standard | 13.3 | 0 | 1 |
| Mild Cognitive Impairment Can Be Distinguished From Alzheimer Disease and Normal Aging for Clinical Trials | 13.3 | 0 | 1 |
| Induction of interactions between CD44 and hyaluronic acid by a short exposure of human T cells to diverse pro-inflammatory mediators | 13.3 | 0 | 1 |
| growth factor signaling initiating cell movement involved in cerebral cortex radial glia guided migration | 13.3 | 0 | 1 |
| 1,3-dichloropropene metabolic process | 13.3 | 0 | 1 |
| initiation of skeletal muscle satellite cell activation by growth factor signaling, involved in skeletal muscle regeneration | 13.3 | 0 | 1 |
| neurotrophin production | 13.3 | 0 | 1 |
| negative regulation of growth factor dependent skeletal muscle satellite cell proliferation | 13.3 | 0 | 1 |
| Meta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in Depression | 13.3 | 0 | 1 |
| Review: Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials | 13.3 | 0 | 1 |
| On the Analysis and Interpretation of Outcome Measures in Stroke Clinical Trials: Lessons From the SAINT I Study of NXY-059 for Acute Ischemic Stroke | 13.3 | 0 | 1 |
| Nykaa | 13.3 | 0 | 1 |
| in silico clinical trials | 13.3 | 0 | 1 |
| Aveeno Baby product line | 13.3 | 0 | 1 |
| CeraVe | 13.3 | 0 | 1 |
| EOS Products, LLC | 13.3 | 0 | 1 |
| Combined effects of Matrigel and growth factors on maintaining undifferentiated murine embryonic stem cells for embryotoxicity testing | 13.3 | 0 | 1 |
| Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors | 13.3 | 0 | 1 |
| Hyaluronic acid binding ability of human sperm reflects cellular maturity and fertilizing potential: selection of sperm for intracytoplasmic sperm injection | 13.3 | 0 | 1 |
| Handling Worker and Third-Party Exposures to Nanotherapeutics During Clinical Trials | 13.3 | 0 | 1 |
| Serum growth factors and oncoproteins in firefighters | 13.3 | 0 | 1 |
| Re: "Estimating the relative risk in cohort studies and clinical trials of common outcomes." | 13.3 | 0 | 1 |
| The pattern of tyrosine phosphorylation in human sperm in response to binding to zona pellucida or hyaluronic acid | 13.3 | 0 | 1 |
| Serum oncoproteins and growth factors in asbestosis and silicosis patients | 13.3 | 0 | 1 |
| Benzene and Its Principal Metabolites Modulate Proinflammatory Cytokines and Growth Factors in Human Epidermal Keratinocyte Cultures | 13.3 | 0 | 1 |
| Serum growth factors in asbestosis patients | 13.3 | 0 | 1 |
| Arsenic induces overexpression of growth factors in human keratinocytes | 13.3 | 0 | 1 |
| Hyaluronic acid binding by human sperm indicates cellular maturity, viability, and unreacted acrosomal status. | 13.3 | 0 | 1 |
| PP22. Revealed preferences in clinical trials | 13.3 | 0 | 1 |
| Growth factors for treating diabetic foot ulcers | 13.3 | 0 | 1 |
| Hyaluronic acid and other conservative treatment options for osteoarthritis of the ankle | 13.3 | 0 | 1 |
| Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors | 13.3 | 0 | 1 |
| Growth factors for angiogenesis in peripheral arterial disease | 13.3 | 0 | 1 |
| Decision aids for people considering taking part in clinical trials | 13.3 | 0 | 1 |
| Audio-visual presentation of information for informed consent for participation in clinical trials | 13.3 | 0 | 1 |
| Eliciting adverse effects data from participants in clinical trials | 13.3 | 0 | 1 |
| Extended discussion of information for informed consent for participation in clinical trials | 13.3 | 0 | 1 |
| Growth factors for chronic kidney disease in adults | 13.3 | 0 | 1 |
| Skin-to-skin care for procedural pain in neonates | 13.3 | 0 | 1 |
| Decision support interventions for people making decisions about participation in clinical trials | 13.3 | 0 | 1 |
| Growth factors for treating diabetic foot ulcers | 13.3 | 0 | 1 |
| Anti-hypertensive drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies and clinical trials | 13.3 | 0 | 1 |
| International clinical trials day & the cochrane library | 13.3 | 0 | 1 |
| Anti-hypertensive drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies and clinical trials | 13.3 | 0 | 1 |
| We need access to all data from all clinical trials | 13.3 | 0 | 1 |
| Skin-to-skin care for procedural pain in neonates | 13.3 | 0 | 1 |
| Publication bias in clinical trials due to statistical significance or direction of trial results | 13.3 | 0 | 1 |
| Chlorhexidine skin care for the prevention of infection in term neonates | 13.3 | 0 | 1 |
| Growth factors for chronic kidney disease in adults | 13.3 | 0 | 1 |
| Hyaluronic Acid inclusion in embryo transfer media for assisted reproductive technologies | 13.3 | 0 | 1 |
| Audio-visual presentation of information for informed consent for participation in clinical trials | 13.3 | 0 | 1 |
| Haemopoietic growth factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke | 13.3 | 0 | 1 |
| Comparison of clinical efficacy of serotonin receptor antagonists in highly emetogenic chemotherapy | 13.3 | 0 | 1 |
| Time to publication for results of clinical trials | 13.3 | 0 | 1 |
| Publication bias in clinical trials | 13.3 | 0 | 1 |
| Embracing failure: What the Phase III progesterone studies can teach about TBI clinical trials | 13.3 | 0 | 1 |
| Interpreting Results of Clinical Trials: A Conceptual Framework | 13.3 | 0 | 1 |
| Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal | 13.3 | 0 | 1 |
| The thresholds for statistical and clinical significance - a five-step procedure for evaluation of intervention effects in randomised clinical trials | 13.3 | 0 | 1 |
| Meeting the demand for pediatric clinical trials | 13.3 | 0 | 1 |
| Use of Patient-Reported Outcomes in Randomized, Double-Blind, Placebo-Controlled Clinical Trials | 13.3 | 0 | 1 |
| Access to Patient-Level Data from GlaxoSmithKline Clinical Trials | 13.3 | 0 | 1 |
| Conflicts of Interest, Selective Inertia, and Research Malpractice in Randomized Clinical Trials: An Unholy Trinity | 13.3 | 0 | 1 |
| Multiple fibroblast growth factors support growth of the ureteric bud but have different effects on branching morphogenesis | 13.3 | 0 | 1 |
| ZNRF2 is released from membranes by growth factors and, together with ZNRF1, regulates the Na+/K+ATPase | 13.3 | 0 | 1 |
| Fibroblast growth factors 7 and 10 are expressed in the human embryonic pancreatic mesenchyme and promote the proliferation of embryonic pancreatic epithelial cells | 13.3 | 0 | 1 |
| Effects of insulin-like growth factors and insulin-like growth factor binding protein-2 on the in vitro proliferation of peripheral blood mononuclear cells | 13.3 | 0 | 1 |
| Genomic sequence of hst, a transforming gene encoding a protein homologous to fibroblast growth factors and the int-2-encoded protein | 13.3 | 0 | 1 |
| Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signaling | 13.3 | 0 | 1 |
| The human FGF-5 oncogene encodes a novel protein related to fibroblast growth factors | 13.3 | 0 | 1 |
| Structure of the Ca2+/S100B/NDR kinase peptide complex: insights into S100 target specificity and activation of the kinase | 13.3 | 0 | 1 |
| Opposite regulation of transforming growth factors-beta2 and -beta3 expression in the human endometrium | 13.3 | 0 | 1 |
| Bone formation zones in heterotopic ossifications: histologic findings and increased expression of bone morphogenetic protein 2 and transforming growth factors beta2 and beta3 | 13.3 | 0 | 1 |
| Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors | 13.3 | 0 | 1 |
| Wnt signaling protects 3T3-L1 preadipocytes from apoptosis through induction of insulin-like growth factors | 13.3 | 0 | 1 |
| Complete sequence of a human receptor for acidic and basic fibroblast growth factors | 13.3 | 0 | 1 |
| The adaptor protein Tom1L1 is a negative regulator of Src mitogenic signaling induced by growth factors | 13.3 | 0 | 1 |
| Kallikrein-related peptidase 12 hydrolyzes matricellular proteins of the CCN family and modifies interactions of CCN1 and CCN5 with growth factors | 13.3 | 0 | 1 |
| WFIKKN1 and WFIKKN2 bind growth factors TGFβ1, BMP2 and BMP4 but do not inhibit their signalling activity | 13.3 | 0 | 1 |
| Diverse forms of a receptor for acidic and basic fibroblast growth factors | 13.3 | 0 | 1 |
| Expression and functions of the vascular endothelial growth factors and their receptors in human basophils | 13.3 | 0 | 1 |
| Stimulation of DNA synthesis in chicken muscle satellite cells by insulin and insulin-like growth factors: evidence for exclusive mediation by a type-I insulin-like growth factor receptor | 13.3 | 0 | 1 |
| E2A basic-helix-loop-helix transcription factors are negatively regulated by serum growth factors and by the Id3 protein | 13.3 | 0 | 1 |
| Molecular cloning of human fibroblast hyaluronic acid-binding protein confirms its identity with P-32, a protein co-purified with splicing factor SF2. Hyaluronic acid-binding protein as P-32 protein, co-purified with splicing factor SF2 | 13.3 | 0 | 1 |
| Ethnic disparity in the relationship between obesity and plasma insulin-like growth factors: the multiethnic cohort | 13.3 | 0 | 1 |
| Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects | 13.3 | 0 | 1 |
| The cytoplasmic tyrosine kinase FER is associated with the catenin-like substrate pp120 and is activated by growth factors | 13.3 | 0 | 1 |
| Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system | 13.3 | 0 | 1 |
| Functional interface between cathepsins and growth factors in the kidney development | 13.3 | 0 | 1 |
| Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells | 13.3 | 0 | 1 |
| Characterization and molecular cloning of a putative binding protein for heparin-binding growth factors | 13.3 | 0 | 1 |
| Solution structure of the human Grb7-SH2 domain/erbB2 peptide complex and structural basis for Grb7 binding to ErbB2 | 13.3 | 0 | 1 |
| Structure of a specific peptide complex of the carboxy-terminal SH2 domain from the p85 alpha subunit of phosphatidylinositol 3-kinase | 13.3 | 0 | 1 |
| The effects of growth factors on the proliferation and in vitro angiogenesis of human macular inner choroidal endothelial cells | 13.3 | 0 | 1 |
| Fibroblast growth factors 2, 4, and 8 exert both negative and positive effects on limb, frontonasal, and mandibular chondrogenesis via MEK-ERK activation | 13.3 | 0 | 1 |
| CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2 | 13.3 | 0 | 1 |
| Modulation of guanine nucleotides bound to Ras in NIH3T3 cells by oncogenes, growth factors, and the GTPase activating protein (GAP) | 13.3 | 0 | 1 |
| Proliferation-associated POU4F2/Brn-3b transcription factor expression is regulated by oestrogen through ERα and growth factors via MAPK pathway | 13.3 | 0 | 1 |
| NSABP breast cancer clinical trials: recent results and future directions | 13.3 | 0 | 1 |
| A change in scientific approach: from alternation to randomised allocation in clinical trials in the 1940s | 13.3 | 0 | 1 |
| Statistics notes: blinding in clinical trials and other studies | 13.3 | 0 | 1 |
| Hyaluronic acid in human articular cartilage. Age-related changes in content and size | 13.3 | 0 | 1 |
| Growth factors induce differential phosphorylation profiles of the Hrs-STAM complex: a common node in signalling networks with signal-specific properties | 13.3 | 0 | 1 |
| The integrin alphavbeta3 is a receptor for the latency-associated peptides of transforming growth factors beta1 and beta3 | 13.3 | 0 | 1 |
| Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials | 13.3 | 0 | 1 |
| Clindamycin as an antimalarial drug: review of clinical trials | 13.3 | 0 | 1 |
| Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid | 13.3 | 0 | 1 |
| Human ADA2 belongs to a new family of growth factors with adenosine deaminase activity | 13.3 | 0 | 1 |
| A coarse-grained molecular model for glycosaminoglycans: application to chondroitin, chondroitin sulfate, and hyaluronic acid. | 13.3 | 0 | 1 |
| The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1 | 13.3 | 0 | 1 |
| Studies in fetal wound healing. V. A prolonged presence of hyaluronic acid characterizes fetal wound fluid | 13.3 | 0 | 1 |
| HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1. | 13.3 | 0 | 1 |
| Fibroblast growth factors | 13.3 | 0 | 1 |
| Clinical trials in head injury | 13.3 | 0 | 1 |
| A functional YY1 binding site is necessary and sufficient to activate Surf-1 promoter activity in response to serum growth factors | 13.3 | 0 | 1 |
| Unconventional anticancer agents: a systematic review of clinical trials | 13.3 | 0 | 1 |
| A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network | 13.3 | 0 | 1 |
| Missing data in randomized clinical trials for weight loss: scope of the problem, state of the field, and performance of statistical methods | 13.3 | 0 | 1 |
| Experimental and clinical results with proximal end-to-end duodenojejunostomy for pathologic duodenogastric reflux | 13.3 | 0 | 1 |
| Next stop, don't block the doors: opening up access to clinical trials results | 13.3 | 0 | 1 |
| Growth factors can influence cell growth and survival through effects on glucose metabolism | 13.3 | 0 | 1 |
| The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hematopoietic growth factors | 13.3 | 0 | 1 |
| Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci | 13.3 | 0 | 1 |
| Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection | 13.3 | 0 | 1 |
| The structure of granulocyte-colony-stimulating factor and its relationship to other growth factors | 13.3 | 0 | 1 |
| Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials | 13.3 | 0 | 1 |
| Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors | 13.3 | 0 | 1 |
| The treatment of eczema with Chinese herbs: a systematic review of randomized clinical trials | 13.3 | 0 | 1 |
| Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design | 13.3 | 0 | 1 |
| Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples | 13.3 | 0 | 1 |
| The myth of equipoise in phase 1 clinical trials | 13.3 | 0 | 1 |
| Targeted disruption of the c-fos gene demonstrates c-fos-dependent and -independent pathways for gene expression stimulated by growth factors or oncogenes | 13.3 | 0 | 1 |
| Altered brain mitochondrial metabolism in healthy aging as assessed by in vivo magnetic resonance spectroscopy | 13.3 | 0 | 1 |
| Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma | 13.3 | 0 | 1 |
| A Brief History of Placebos and Clinical Trials in Psychiatry | 13.3 | 0 | 1 |
| Clinical efficacy of Shodhana Karma and Shamana Karma in Mandala Kushtha (Psoriasis) | 13.3 | 0 | 1 |
| Double-Blind Clinical Trials of Oral Cyclacillin and Ampicillin | 13.3 | 0 | 1 |
| Efficacy of carboplatin-taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials | 13.3 | 0 | 1 |
| Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part III – convergence toward clinical trials | 13.3 | 0 | 1 |
| Identification of a cysteine-rich receptor for fibroblast growth factors | 13.3 | 0 | 1 |
| Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT | 13.3 | 0 | 1 |
| Vaccinia virus 19-kilodalton protein: relationship to several mammalian proteins, including two growth factors | 13.3 | 0 | 1 |
| Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02 | 13.3 | 0 | 1 |
| Acupuncture for the treatment of tinnitus: a systematic review of randomized clinical trials | 13.3 | 0 | 1 |
| Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics | 13.3 | 0 | 1 |
| Sequence of the notch locus of Drosophila melanogaster: relationship of the encoded protein to mammalian clotting and growth factors | 13.3 | 0 | 1 |
| Comfrey root: from tradition to modern clinical trials | 13.3 | 0 | 1 |
| Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence | 13.3 | 0 | 1 |
| Population-Based Inorganic Mercury Biomonitoring and the Identification of Skin Care Products as a Source of Exposure in New York City | 13.3 | 0 | 1 |
| Improving the reliability of stroke disability grading in clinical trials and clinical practice: the Rankin Focused Assessment (RFA). | 13.3 | 0 | 1 |
| Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trials | 13.3 | 0 | 1 |
| Phase I dose-escalation study of the novel antiandrogen BMS-641988 in patients with castration-resistant prostate cancer | 13.3 | 0 | 1 |
| Stroke prevention in atrial fibrillation: latest clinical trials and guidelines | 13.3 | 0 | 1 |
| Endocrine fibroblast growth factors 15/19 and 21: from feast to famine | 13.3 | 0 | 1 |
| Evaluation of the clinical efficacy of asenapine in schizophrenia | 13.3 | 0 | 1 |
| Cellular treatments for spinal cord injury: the time is right for clinical trials | 13.3 | 0 | 1 |
| Chiropractic Treatment for Gastrointestinal Problems: A Systematic Review of Clinical Trials | 13.3 | 0 | 1 |
| Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group study | 13.3 | 0 | 1 |
| Hepatotoxicity observed in clinical trials of aplaviroc (GW873140) | 13.3 | 0 | 1 |
| Transcription of the muscle regulatory gene Myf4 is regulated by serum components, peptide growth factors and signaling pathways involving G proteins | 13.3 | 0 | 1 |
| One-year brain atrophy evident in healthy aging | 13.3 | 0 | 1 |
| Interactions between Growth Factors and Integrins: Latent Forms of Transforming Growth Factor-β Are Ligands for the Integrin αvβ1 | 13.3 | 0 | 1 |
| The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex | 13.3 | 0 | 1 |
| Systematic review of clinical efficacy of topical treatments for head lice | 13.3 | 0 | 1 |
| Solution structure of the human Grb14-SH2 domain and comparison with the structures of the human Grb7-SH2/erbB2 peptide complex and human Grb10-SH2 domain | 13.3 | 0 | 1 |
| Acupuncture treatment for pain: systematic review of randomised clinical trials with acupuncture, placebo acupuncture, and no acupuncture groups | 13.3 | 0 | 1 |
| Ost's (2008) methodological comparison of clinical trials of acceptance and commitment therapy versus cognitive behavior therapy: Matching apples with oranges? | 13.3 | 0 | 1 |
| Neuraminidase-1, a subunit of the cell surface elastin receptor, desialylates and functionally inactivates adjacent receptors interacting with the mitogenic growth factors PDGF-BB and IGF-2 | 13.3 | 0 | 1 |
| Reinforcement learning design for cancer clinical trials | 13.3 | 0 | 1 |
| Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials | 13.3 | 0 | 1 |
| The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia | 13.3 | 0 | 1 |
| Reporting on sex-based analysis in clinical trials of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker efficacy | 13.3 | 0 | 1 |
| Misclassification of drug failure in Plasmodium falciparum clinical trials in southeast Asia | 13.3 | 0 | 1 |
| Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration | 13.3 | 0 | 1 |
| Template for developing guidelines for the evaluation of the clinical efficacy of psychophysiological interventions | 13.3 | 0 | 1 |
| St John's wort for depression--an overview and meta-analysis of randomised clinical trials | 13.3 | 0 | 1 |
| Monitoring Pc 4 photodynamic therapy in clinical trials of cutaneous T-cell lymphoma using noninvasive spectroscopy | 13.3 | 0 | 1 |
| Use of hyaluronic acid fillers for the treatment of the aging face | 13.3 | 0 | 1 |
| James Fries: healthy aging pioneer | 13.3 | 0 | 1 |
| Clinical efficacy of three common treatments in acute otitis externa in primary care: randomised controlled trial | 13.3 | 0 | 1 |
| Bandit solutions provide unified ethical models for randomized clinical trials and comparative effectiveness research | 13.3 | 0 | 1 |
| A patient-level data meta-analysis of standard-of-care treatments from eight prostate cancer clinical trials | 13.3 | 0 | 1 |
| Standardizing in vitro diagnostics tasks in clinical trials: a call for action | 13.3 | 0 | 1 |
| Tropic Skin Care | 13.3 | 0 | 1 |
| Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis | 13.3 | 0 | 1 |
| Use of Dinitrophenol in Nutritional Disorders : A Critical Survey of Clinical Results | 13.3 | 0 | 1 |
| A systematic review and meta-analysis of clinical trials on physical interventions for lateral epicondylalgia | 13.3 | 0 | 1 |
| Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies | 13.3 | 0 | 1 |
| Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D | 13.3 | 0 | 1 |
| Identification of hyaluronic acid binding sites in the extracellular domain of CD44 | 13.3 | 0 | 1 |
| The Internet and clinical trials: background, online resources, examples and issues | 13.3 | 0 | 1 |
| Preliminary results of early clinical trials with the fully human anti-TNFalpha monoclonal antibody D2E7 | 13.3 | 0 | 1 |
| Clinical trials of homoeopathy | 13.3 | 0 | 1 |
| THE HYDROLYSIS OF HYALURONIC ACID BY BACTERIAL ENZYMES | 13.3 | 0 | 1 |
| Clinical trials of oral contraceptives | 13.3 | 0 | 1 |
| Fertility testing and ICSI sperm selection by hyaluronic acid binding: clinical and genetic aspects | 13.3 | 0 | 1 |
| fibroblast growth factor family | 13.3 | 0 | 1 |
| Intracellular hyaluronic acid binding protein | 13.3 | 0 | 1 |
| Transforming growth factors-beta are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system. | 13.3 | 0 | 1 |
| Validity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trials | 13.3 | 0 | 1 |
| Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them! | 13.3 | 0 | 1 |
| Developing an HIV vaccine: the role of efficacy studies in nonhuman primates | 13.3 | 0 | 1 |
| Clinical trials in developing countries: Discussions at the '9th International Symposium on Long Term Clinical Trials', London, UK, 19-20 June 2000 | 13.3 | 0 | 1 |
| Chondrocyte response to growth factors is modulated by p38 mitogen-activated protein kinase inhibition | 13.3 | 0 | 1 |
| A review of clinical trials in dietary interventions to decrease the incidence of coronary artery disease | 13.3 | 0 | 1 |
| Use of diffusion and perfusion magnetic resonance imaging as a tool in acute stroke clinical trials | 13.3 | 0 | 1 |
| Problems in dealing with missing data and informative censoring in clinical trials | 13.3 | 0 | 1 |
| Endometrial glands as a source of nutrients, growth factors and cytokines during the first trimester of human pregnancy: a morphological and immunohistochemical study | 13.3 | 0 | 1 |
| Measuring and reporting quality of life outcomes in clinical trials in cystic fibrosis: a critical review | 13.3 | 0 | 1 |
| The efficacy of duloxetine: a comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trials | 13.3 | 0 | 1 |
| Killing Bugs at the Bedside: a prospective hospital survey of how frequently personal digital assistants provide expert recommendations in the treatment of infectious diseases | 13.3 | 0 | 1 |
| International Retrovirology Association brings together scientists and clinicians to bridge discoveries about human T-lymphotropic viruses from the laboratory to clinical trials | 13.3 | 0 | 1 |
| The role of the clinical research coordinator--data manager--in oncology clinical trials | 13.3 | 0 | 1 |
| Are proton pump inhibitors the first choice for acute treatment of gastric ulcers? A meta analysis of randomized clinical trials | 13.3 | 0 | 1 |
| The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia | 13.3 | 0 | 1 |
| A systematic review of the quality of homeopathic clinical trials | 13.3 | 0 | 1 |
| A taxpayer-funded clinical trials registry and results database | 13.3 | 0 | 1 |
| Growth factors in idiopathic pulmonary fibrosis: relative roles | 13.3 | 0 | 1 |
| Growth factors in lung development and disease: friends or foe? | 13.3 | 0 | 1 |
| Biventricular pacing in heart failure: update on results from clinical trials | 13.3 | 0 | 1 |
| The measurement of health-related quality of life (QOL) in paediatric clinical trials: a systematic review | 13.3 | 0 | 1 |
| Determinants of patient recruitment in a multicenter clinical trials group: trends, seasonality and the effect of large studies | 13.3 | 0 | 1 |
| Insulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function | 13.3 | 0 | 1 |
| Can generic paediatric mortality scores calculated 4 hours after admission be used as inclusion criteria for clinical trials? | 13.3 | 0 | 1 |
| Impact on the quality of life of lymphoedema patients following introduction of a hygiene and skin care regimen in a Guyanese community endemic for lymphatic filariasis: A preliminary clinical intervention study | 13.3 | 0 | 1 |
| Cumulus expansion, nuclear maturation and connexin 43, cyclooxygenase-2 and FSH receptor mRNA expression in equine cumulus-oocyte complexes cultured in vitro in the presence of FSH and precursors for hyaluronic acid synthesis | 13.3 | 0 | 1 |
| Tyrosine kinase signalling in breast cancer: fibroblast growth factors and their receptors | 13.3 | 0 | 1 |
| Inhibition of antithrombin by hyaluronic acid may be involved in the pathogenesis of rheumatoid arthritis | 13.3 | 0 | 1 |
| Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action | 13.3 | 0 | 1 |
| Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity | 13.3 | 0 | 1 |
| Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials | 13.3 | 0 | 1 |
| Breast cancer research and the European Union Clinical Trials Directive | 13.3 | 0 | 1 |
| Introducing Breast Cancer Research's updates on clinical trials | 13.3 | 0 | 1 |
| On the probability of cost-effectiveness using data from randomized clinical trials | 13.3 | 0 | 1 |
| Clinical trials update of the European Organization for Research and Treatment of Cancer Breast Cancer Group | 13.3 | 0 | 1 |
| Do we need clinical trials to test the ability of transdermal HRT to prevent coronary heart disease? | 13.3 | 0 | 1 |
| Polymorphism in the Plasmodium falciparum chloroquine-resistance transporter protein links verapamil enhancement of chloroquine sensitivity with the clinical efficacy of amodiaquine | 13.3 | 0 | 1 |
| Differential clinical efficacy of anti-CD4 monoclonal antibodies in rat adjuvant arthritis is paralleled by differential influence on NF-kappaB binding activity and TNF-alpha secretion of T cells | 13.3 | 0 | 1 |
| A new vision for clinical trials in Africa | 13.3 | 0 | 1 |
| Hepatocyte and keratinocyte growth factors and their receptors in human lung emphysema | 13.3 | 0 | 1 |
| Suicide attempts in clinical trials with paroxetine randomised against placebo | 13.3 | 0 | 1 |
| The ugly side of beauty products | 13.3 | 0 | 1 |
| When clinical trials are compromised: a perspective from a patient advocate | 13.3 | 0 | 1 |
| The therapeutic effect of clinical trials: understanding placebo response rates in clinical trials--a secondary analysis | 13.3 | 0 | 1 |
| Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. | 13.3 | 0 | 1 |
| Early stopping of clinical trials | 13.3 | 0 | 1 |
| Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda | 13.3 | 0 | 1 |
| Medical journals, academia, and industry-sponsored clinical trials | 13.3 | 0 | 1 |
| Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus | 13.3 | 0 | 1 |
| Toxicity tests: "inert" and active ingredients | 13.3 | 0 | 1 |
| The practice of Korean medicine: an overview of clinical trials in acupuncture | 13.3 | 0 | 1 |
| Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports | 13.3 | 0 | 1 |
| Intra-articular injections of high-molecular-weight hyaluronic acid have biphasic effects on joint inflammation and destruction in rat antigen-induced arthritis | 13.3 | 0 | 1 |
| Dual activation of pathways regulated by steroid receptors and peptide growth factors in primary prostate cancer revealed by Factor Analysis of microarray data | 13.3 | 0 | 1 |
| Insulin-like growth factor receptor | 13.3 | 0 | 1 |
| Understanding the attitudes of the elderly towards enrolment into cancer clinical trials | 13.3 | 0 | 1 |
| Sequential boundaries approach in clinical trials with unequal allocation ratios. | 13.3 | 0 | 1 |
| Actin and agonist MHC-peptide complex-dependent T cell receptor microclusters as scaffolds for signaling | 13.3 | 0 | 1 |
| Luxury packaging | 13.3 | 0 | 1 |
| Category:Clinical trials related to cardiology | 13.3 | 0 | 1 |
| Leeds Institute of Clinical Trials Research | 13.3 | 0 | 1 |
| DNA vaccines against Zika virus speed into clinical trials | 13.3 | 0 | 1 |
| Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women | 13.3 | 0 | 1 |
| Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors | 13.3 | 0 | 1 |
| Dressings and topical agents containing hyaluronic acid for chronic wound healing | 13.3 | 0 | 1 |
| Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic Review | 13.3 | 0 | 1 |
| Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical Trials | 13.3 | 0 | 1 |
| Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials | 13.3 | 0 | 1 |
| Patient-Reported Outcomes in Metastatic Breast Cancer: A Review of Industry-Sponsored Clinical Trials | 13.3 | 0 | 1 |
| The European Organization for Research and Treatment of Cancer perspective on designing clinical trials with immune therapeutics | 13.3 | 0 | 1 |
| Personalized Clinical Trials in Hepatocellular Carcinoma Based on Biomarker Selection | 13.3 | 0 | 1 |
| Individualizing endpoints in randomized clinical trials to better inform individual patient care: the TARGET proposal | 13.3 | 0 | 1 |
| The Blood and Marrow Transplant Clinical Trials Network: An Effective Infrastructure for Addressing Important Issues in Hematopoietic Cell Transplantation | 13.3 | 0 | 1 |
| Biomarkers of intestinal fibrosis - one step towards clinical trials for stricturing inflammatory bowel disease | 13.3 | 0 | 1 |
| Adaptive Designs for Clinical Trials | 13.3 | 0 | 1 |
| A review of the clinical efficacy and safety of MP-AzeFlu, a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, in clinical studies conducted during different allergy seasons in the US | 13.3 | 0 | 1 |
| Recent advances in innovative therapeutic approaches for Duchenne muscular dystrophy: from discovery to clinical trials | 13.3 | 0 | 1 |
| Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials? | 13.3 | 0 | 1 |
| The treatment of chronic depression with cognitive behavioral analysis system of psychotherapy: a systematic review and meta-analysis of randomized-controlled clinical trials | 13.3 | 0 | 1 |
| Revolutionizing Alzheimer's disease and clinical trials through biomarkers | 13.3 | 0 | 1 |
| Basic concepts for sample size calculation: Critical step for any clinical trials! | 13.3 | 0 | 1 |
| Neuropharmacological efficacy of the traditional Japanese Kampo medicine yokukansan and its active ingredients | 13.3 | 0 | 1 |
| Genetic basis for hyper production of hyaluronic acid in natural and engineered microorganisms | 13.3 | 0 | 1 |
| The transcorneal electrical stimulation as a novel therapeutic strategy against retinal and optic neuropathy: a review of experimental and clinical trials | 13.3 | 0 | 1 |
| Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis | 13.3 | 0 | 1 |
| A review of approaches to improve participation of culturally and linguistically diverse populations in clinical trials | 13.3 | 0 | 1 |
| Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials | 13.3 | 0 | 1 |
| Effects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical Trials | 13.3 | 0 | 1 |
| Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy | 13.3 | 0 | 1 |
| Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years | 13.3 | 0 | 1 |
| Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI) | 13.3 | 0 | 1 |
| Designing exercise clinical trials for older adults with cancer: Recommendations from 2015 Cancer and Aging Research Group NCI U13 Meeting | 13.3 | 0 | 1 |
| A commentary on randomized clinical trials: How to produce them with a good level of evidence | 13.3 | 0 | 1 |
| Multi-regional clinical trials and global drug development | 13.3 | 0 | 1 |
| Corticosteroids in the adjunctive therapy of community-acquired pneumonia: an appraisal of recent meta-analyses of clinical trials | 13.3 | 0 | 1 |
| Clinical Efficacy of Stem Cell Therapy for Diabetes Mellitus: A Meta-Analysis | 13.3 | 0 | 1 |
| Does larch arabinogalactan enhance immune function? A review of mechanistic and clinical trials | 13.3 | 0 | 1 |
| The Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical Trials | 13.3 | 0 | 1 |
| Involvement of Fibroblast Growth Factors and Their Receptors in Epididymo-Testicular Descent and Maldescent | 13.3 | 0 | 1 |
| Role of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trials | 13.3 | 0 | 1 |
| Insulin‐like growth factors and their potential role in cardiac epigenetics | 13.3 | 0 | 1 |
| Study design in evidence-based surgery: What is the role of case-control studies? | 13.3 | 0 | 1 |
| Mechanical thrombectomy for emergent large vessel occlusion: a critical appraisal of recent randomized controlled clinical trials | 13.3 | 0 | 1 |
| Daclatasvir–sofosbuvir combination therapy with or without ribavirin for hepatitis C virus infection: from the clinical trials to real life | 13.3 | 0 | 1 |
| From Patient to Patient--Sharing the Data from Clinical Trials | 13.3 | 0 | 1 |
| Manufacturing of recombinant adeno-associated viral vectors for clinical trials | 13.3 | 0 | 1 |
| Will testosterone replacement therapy become a new treatment of chronic heart failure? A review based on 8 clinical trials | 13.3 | 0 | 1 |
| The mTOR pathway in obesity driven gastrointestinal cancers: Potential targets and clinical trials | 13.3 | 0 | 1 |
| Molecular Testing and the Pathologist's Role in Clinical Trials of Breast Cancer | 13.3 | 0 | 1 |
| Hyaluronic acid as a biomarker of fibrosis in chronic liver diseases of different etiologies | 13.3 | 0 | 1 |
| Clinical Efficacy of Electroneurography in Acute Facial Paralysis | 13.3 | 0 | 1 |
| Clinical efficacy and safety of evolocumab for low-density lipoprotein cholesterol reduction | 13.3 | 0 | 1 |
| Shensongyangxin Capsules for Paroxysmal Atrial Fibrillation: A Systematic Review of Randomized Clinical Trials | 13.3 | 0 | 1 |
| Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease | 13.3 | 0 | 1 |
| Adaptive designs undertaken in clinical research: a review of registered clinical trials | 13.3 | 0 | 1 |
| Quality Randomized Clinical Trials of Topical Diabetic Foot Ulcer Healing Agents | 13.3 | 0 | 1 |
| The Efficacy and Safety of Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors for Advanced Melanoma: A Meta-Analysis of Clinical Trials Following the PRISMA Guidelines | 13.3 | 0 | 1 |
| Regulation of mTORC1 by growth factors, energy status, amino acids and mechanical stimuli at a glance | 13.3 | 0 | 1 |
| The challenge of comorbidity in clinical trials for multiple sclerosis | 13.3 | 0 | 1 |
| The Evolving Biology of Castration-Resistant Prostate Cancer: Review of Recommendations From the Prostate Cancer Clinical Trials Working Group 3 | 13.3 | 0 | 1 |
| Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials | 13.3 | 0 | 1 |
| Understanding the molecular mechanisms of cancer prevention by dietary phytochemicals: From experimental models to clinical trials | 13.3 | 0 | 1 |
| KRAS oncogene in lung cancer: focus on molecularly driven clinical trials | 13.3 | 0 | 1 |
| Current Molecular Targeted Therapy in Advanced Gastric Cancer: A Comprehensive Review of Therapeutic Mechanism, Clinical Trials, and Practical Application | 13.3 | 0 | 1 |
| Dietary restriction with and without caloric restriction for healthy aging | 13.3 | 0 | 1 |
| Treatment of osteoporosis with eldecalcitol, a new vitamin D analog: a comprehensive review and meta-analysis of randomized clinical trials | 13.3 | 0 | 1 |
| Clinical evidence in the treatment of rotator cuff tears with hyaluronic acid | 13.3 | 0 | 1 |
| Hyaluronic acid and tendon lesions | 13.3 | 0 | 1 |
| Clinical trials in retinal dystrophies | 13.3 | 0 | 1 |
| Clinical Trials in Branch Retinal Vein Occlusion | 13.3 | 0 | 1 |
| Update on Clinical Trials in Dry Age-related Macular Degeneration | 13.3 | 0 | 1 |
| Updates on the clinical trials in diabetic macular edema | 13.3 | 0 | 1 |
| Update on clinical trials in home mechanical ventilation | 13.3 | 0 | 1 |
| Gene Therapy in Cardiac Surgery: Clinical Trials, Challenges, and Perspectives | 13.3 | 0 | 1 |
| Caries-Preventive Effect of High-Viscosity Glass Ionomer and Resin-Based Fissure Sealants on Permanent Teeth: A Systematic Review of Clinical Trials | 13.3 | 0 | 1 |
| Results of clinical trials with anti-programmed death 1/programmed death ligand 1 inhibitors in lung cancer | 13.3 | 0 | 1 |
| Clinical efficacy and drug resistance of anti-epidermal growth factor receptor therapy in colorectal cancer | 13.3 | 0 | 1 |
| Current Clinical Trials on the Use of Direct Oral Anticoagulants in the Pediatric Population | 13.3 | 0 | 1 |
| The clinical development process for a novel preventive vaccine | 13.3 | 0 | 1 |
| Healthy aging: The ultimate preventative medicine | 13.3 | 0 | 1 |
| Impact of Contextual Factors on the Effect of Interventions to Improve Health Worker Performance in Sub-Saharan Africa: Review of Randomised Clinical Trials | 13.3 | 0 | 1 |
| The Mediterranean Lifestyle as a Non-Pharmacological and Natural Antioxidant for Healthy Aging | 13.3 | 0 | 1 |
| Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis | 13.3 | 0 | 1 |
| Delayed-type Necrosis after Soft-tissue Augmentation with Hyaluronic Acid | 13.3 | 0 | 1 |
| Effects of Sitagliptin on Lipid Profiles in Patients With Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Clinical Trials | 13.3 | 0 | 1 |
| Novel Techniques for Ex Vivo Expansion of Cord Blood: Clinical Trials | 13.3 | 0 | 1 |
| New Insight into the Anti-liver Fibrosis Effect of Multitargeted Tyrosine Kinase Inhibitors: From Molecular Target to Clinical Trials | 13.3 | 0 | 1 |
| Huangqi Jianzhong Tang for Treatment of Chronic Gastritis: A Systematic Review of Randomized Clinical Trials | 13.3 | 0 | 1 |
| Epigenetic treatment of solid tumours: a review of clinical trials | 13.3 | 0 | 1 |
| Adverse Event Recording and Reporting in Clinical Trials Comparing Lumbar Disk Replacement with Lumbar Fusion: A Systematic Review | 13.3 | 0 | 1 |
| Niemann-Pick disease treatment: a systematic review of clinical trials | 13.3 | 0 | 1 |
| Statistical considerations for stopping systemic lupus erythematosus clinical trials earlier | 13.3 | 0 | 1 |
| Measuring free-living physical activity in COPD patients: Deriving methodology standards for clinical trials through a review of research studies | 13.3 | 0 | 1 |
| Elderly patients' participation in clinical trials | 13.3 | 0 | 1 |
| A Comprehensive Review of Clinical Trials on EGFR Inhibitors Such as Cetuximab and Panitumumab as Monotherapy and in Combination for Treatment of Metastatic Colorectal Cancer | 13.3 | 0 | 1 |
| Histone deacetylase inhibitors in castration-resistant prostate cancer: molecular mechanism of action and recent clinical trials | 13.3 | 0 | 1 |
| Plant-based vaccines for animals and humans: recent advances in technology and clinical trials | 13.3 | 0 | 1 |
| Impact of treatment with rosuvastatin and atorvastatin on cardiovascular outcomes: evidence from the Archimedes-simulated clinical trials | 13.3 | 0 | 1 |
| Clinical Trials of Adult Stem Cell Therapy in Patients with Ischemic Stroke | 13.3 | 0 | 1 |
| The Primary Outcome Measure and Its Importance in Clinical Trials | 13.3 | 0 | 1 |
| Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Blepharospasm and Hemifacial Spasm | 13.3 | 0 | 1 |
| Fecal microbiota transplantation: current clinical efficacy and future prospects | 13.3 | 0 | 1 |
| Basic Research on Neurotrophic Factors and Its Application to Medical Uses | 13.3 | 0 | 1 |
| Patient-reported outcomes as end points in clinical trials in rheumatoid arthritis | 13.3 | 0 | 1 |
| Clinical efficacy of dexmedetomidine versus propofol in children undergoing magnetic resonance imaging: a meta-analysis | 13.3 | 0 | 1 |
| Nebulised dornase alfa versus placebo or hypertonic saline in adult critically ill patients: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis | 13.3 | 0 | 1 |
| The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review | 13.3 | 0 | 1 |
| The Cannabis Dilemma: A Review of Its Associated Risks and Clinical Efficacy | 13.3 | 0 | 1 |
| The ethical issues regarding consent to clinical trials with pre-term or sick neonates: a systematic review (framework synthesis) of the empirical research | 13.3 | 0 | 1 |
| Placebo Devices as Effective Control Methods in Acupuncture Clinical Trials: A Systematic Review | 13.3 | 0 | 1 |
| Immunotherapy for pancreatic ductal adenocarcinoma: an overview of clinical trials | 13.3 | 0 | 1 |
| The glycaemic outcomes of Cinnamon, a review of the experimental evidence and clinical trials | 13.3 | 0 | 1 |
| Statistical controversies in clinical research: long-term follow-up of clinical trials in cancer | 13.3 | 0 | 1 |
| Lung protective ventilation in patients undergoing major surgery: a systematic review incorporating a Bayesian approach | 13.3 | 0 | 1 |
| Project Management of Randomized Clinical Trials: A Narrative Review | 13.3 | 0 | 1 |
| Research Advances in Tissue Engineering Materials for Sustained Release of Growth Factors | 13.3 | 0 | 1 |
| Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma (short title) | 13.3 | 0 | 1 |
| A Meta-Analysis of Randomized Clinical Trials Comparing Shorter (Less or Equal Than 6 Months) and Longer (More or Equal Than 12 Months) Dual Anti-Platelet Therapy Following Drug-Eluting Coronary Stents | 13.3 | 0 | 1 |
| Systemic Review and Meta-Analysis of the Clinical Efficacy and Adverse Effects of Zhengqing Fengtongning Combined with Methotrexate in Rheumatoid Arthritis | 13.3 | 0 | 1 |
| Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials | 13.3 | 0 | 1 |
| Fluid Biomarkers in Clinical Trials of Alzheimer’s Disease Therapeutics | 13.3 | 0 | 1 |
| Systematic Review of Randomized Clinical Trials on Safety and Efficacy of Pharmacological and Nonpharmacological Treatments for Retinitis Pigmentosa | 13.3 | 0 | 1 |
| Overestimating the Effects of Healthy Aging | 13.3 | 0 | 1 |
| Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials | 13.3 | 0 | 1 |
| Challenging aspects of treatment strategies in heart failure with preserved ejection fraction: "Why did recent clinical trials fail?" | 13.3 | 0 | 1 |
| Paediatric cardiovascular clinical trials: an analysis of ClinicalTrials.gov and the Food and Drug Administration Pediatric Drug Labeling Database | 13.3 | 0 | 1 |
| Differences between the real and the desired worlds in the results of clinical trials | 13.3 | 0 | 1 |
| Glans Penis Augmentation Using Hyaluronic Acid Gel as an Injectable Filler | 13.3 | 0 | 1 |
| Statistical principles for omics-based clinical trials | 13.3 | 0 | 1 |
| A comparative, randomized, controlled study on clinical efficacy and dental staining reduction of a mouthwash containing Chlorhexidine 0.20% and Anti Discoloration System (ADS) | 13.3 | 0 | 1 |
| The Role of End-of-Life Issues in the Design and Reporting of Cancer Clinical Trials: A Structured Literature Review | 13.3 | 0 | 1 |
| Idiopathic pulmonary fibrosis: from clinical trials to real-life experiences | 13.3 | 0 | 1 |
| Neoadjuvant Rectal (NAR) Score: a New Surrogate Endpoint in Rectal Cancer Clinical Trials | 13.3 | 0 | 1 |
| Putting age-related task activation into large-scale brain networks: A meta-analysis of 114 fMRI studies on healthy aging | 13.3 | 0 | 1 |
| Clinical trials update from the European Society of Cardiology-Heart Failure meeting 2015: AUGMENT-HF, TITRATION, STOP-HF, HARMONIZE, LION HEART, MOOD-HF, and renin-angiotensin inhibitors in patients with heart and renal failure | 13.3 | 0 | 1 |
| Paperless clinical trials: Myth or reality? | 13.3 | 0 | 1 |
| MicroRNAs and Growth Factors: An Alliance Propelling Tumor Progression | 13.3 | 0 | 1 |
| Platelet-derived growth factors (PDGFs) in glomerular and tubulointerstitial fibrosis | 13.3 | 0 | 1 |
| Heterogeneity of primary outcome measures used in clinical trials of treatments for intermediate, posterior, and panuveitis | 13.3 | 0 | 1 |
| The cellular response to vascular endothelial growth factors requires co-ordinated signal transduction, trafficking and proteolysis | 13.3 | 0 | 1 |
| Optimizing the Use of Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: From Clinical Trials to Clinical Practice | 13.3 | 0 | 1 |
| Efficacy of progesterone for moderate to severe traumatic brain injury: a meta-analysis of randomized clinical trials | 13.3 | 0 | 1 |
| Targeting chronic lymphocytic leukemia cells in the tumor microenviroment: A review of the in vitro and clinical trials to date | 13.3 | 0 | 1 |
| Translating clinical trials from human to veterinary oncology and back | 13.3 | 0 | 1 |
| Stem cells and growth factors in wound healing | 13.3 | 0 | 1 |
| Fibronectin Interaction and Enhancement of Growth Factors: Importance for Wound Healing | 13.3 | 0 | 1 |
| Process of care in outpatient Integrative healthcare facilities: a systematic review of clinical trials | 13.3 | 0 | 1 |
| Niacin in the Treatment of Hyperlipidemias in Light of New Clinical Trials: Has Niacin Lost its Place? | 13.3 | 0 | 1 |
| Molecular landscape of prostate cancer: Implications for current clinical trials | 13.3 | 0 | 1 |
| The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials | 13.3 | 0 | 1 |
| Novel Stroke Therapeutics: Unraveling Stroke Pathophysiology and Its Impact on Clinical Treatments | 13.3 | 0 | 1 |
| Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trials | 13.3 | 0 | 1 |
| Religious and spiritual interventions in mental health care: a systematic review and meta-analysis of randomized controlled clinical trials | 13.3 | 0 | 1 |
| Reporting quality of abstracts in phase III clinical trials of systemic therapy in metastatic solid malignancies | 13.3 | 0 | 1 |
| Patient centric approach for clinical trials: Current trend and new opportunities | 13.3 | 0 | 1 |
| Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials | 13.3 | 0 | 1 |
| Future Clinical Trials in DIPG: Bringing Epigenetics to the Clinic | 13.3 | 0 | 1 |
| Heparin in malignant glioma: review of preclinical studies and clinical results | 13.3 | 0 | 1 |
| Antiangiogenesis Therapy for Breast Cancer: An Update and Perspectives from Clinical Trials | 13.3 | 0 | 1 |
| The Inadmissibility of What We Eat in America and NHANES Dietary Data in Nutrition and Obesity Research and the Scientific Formulation of National Dietary Guidelines | 13.3 | 0 | 1 |
| Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date | 13.3 | 0 | 1 |
| Novel Agents for Multiple Myeloma to Overcome Resistance in Phase III Clinical Trials | 13.3 | 0 | 1 |
| Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: a systematic review and meta-analysis of clinical trials | 13.3 | 0 | 1 |
| Confronting diversity in the production of clinical evidence goes beyond merely including under-represented groups in clinical trials | 13.3 | 0 | 1 |
| The Roles of Fibroblast Growth Factors in the Testicular Development and Tumor | 13.3 | 0 | 1 |
| Clinical trials of investigational agents for IPF: a review of a Cochrane report | 13.3 | 0 | 1 |
| Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease | 13.3 | 0 | 1 |
| Clinical Trial Designs in Amyotrophic Lateral Sclerosis: Does One Design Fit All? | 13.3 | 0 | 1 |
| Skin care: Historical and contemporary views | 13.3 | 0 | 1 |
| Delafloxacin, a non-zwitterionic fluoroquinolone in Phase III of clinical development: evaluation of its pharmacology, pharmacokinetics, pharmacodynamics and clinical efficacy | 13.3 | 0 | 1 |
| Molecular landscape of pancreatic cancer: implications for current clinical trials | 13.3 | 0 | 1 |
| Clinical relevance of stem cell therapies in amyotrophic lateral sclerosis | 13.3 | 0 | 1 |
| Spinal muscular atrophy: from gene discovery to clinical trials | 13.3 | 0 | 1 |
| The path to innovative drug development of cancer vaccine: From discovery of tumor antigens to clinical trials | 13.3 | 0 | 1 |
| Transposon-based vector systems for gene therapy clinical trials: challenges and considerations | 13.3 | 0 | 1 |
| Observer bias in randomized clinical trials with time-to-event outcomes: systematic review of trials with both blinded and non-blinded outcome assessors | 13.3 | 0 | 1 |
| Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report | 13.3 | 0 | 1 |
| Aspects of vulnerable patients and informed consent in clinical trials | 13.3 | 0 | 1 |
| Flexible dosing with fesoterodine 4 and 8 mg: a systematic review of data from clinical trials | 13.3 | 0 | 1 |
| Sample size determinations in original research protocols for randomised clinical trials submitted to UK research ethics committees: review | 13.3 | 0 | 1 |
| OARSI Clinical Trials Recommendations: An abbreviated regulatory guide to the clinical requirements for development of therapeutics in osteoarthritis | 13.3 | 0 | 1 |
| Essential rules and requirements for global clinical trials in rare lung diseases: A sponsor׳s standpoint | 13.3 | 0 | 1 |
| National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report | 13.3 | 0 | 1 |
| Effectiveness of holistic interventions for people with severe chronic obstructive pulmonary disease: systematic review of controlled clinical trials | 13.3 | 0 | 1 |
| The effect of tree nut, peanut, and soy nut consumption on blood pressure: a systematic review and meta-analysis of randomized controlled clinical trials | 13.3 | 0 | 1 |
| Is there a linear relationship between the dose of ruminant trans-fatty acids and cardiovascular risk markers in healthy subjects: results from a systematic review and meta-regression of randomised clinical trials | 13.3 | 0 | 1 |
| Radiotherapy protocol deviations and clinical outcomes: a meta-analysis of cooperative group clinical trials | 13.3 | 0 | 1 |
| Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials | 13.3 | 0 | 1 |
| A systematic review of Chinese randomized clinical trials of SSRI treatment of depression | 13.3 | 0 | 1 |
| Current status and clinical trials of laparoendoscopic single-site colorectal surgery | 13.3 | 0 | 1 |
| Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials | 13.3 | 0 | 1 |
| Assessment of clinical practice guideline methodology for the treatment of knee osteoarthritis with intra-articular hyaluronic acid | 13.3 | 0 | 1 |
| Q26829699 | 13.3 | 0 | 1 |
| Q26829776 | 13.3 | 0 | 1 |
| Neuraxial anesthesia for orthopedic surgery: systematic review and meta-analysis of randomized clinical trials | 13.3 | 0 | 1 |
| Q26829905 | 13.3 | 0 | 1 |
| Are We Missing the Importance of Missing Values in HIV Prevention Randomized Clinical Trials? Review and Recommendations | 13.3 | 0 | 1 |
| How to share results of clinical trials with study participants? | 13.3 | 0 | 1 |
| Systematic literature review of abobotulinumtoxinA in clinical trials for adult upper limb spasticity | 13.3 | 0 | 1 |
| Lung clearance index: evidence for use in clinical trials in cystic fibrosis | 13.3 | 0 | 1 |
| Random allocation in controlled clinical trials: a review | 13.3 | 0 | 1 |
| OpenTrials: towards a collaborative open database of all available information on all clinical trials | 13.3 | 0 | 1 |
| Primary and secondary outcomes in oncology clinical trials: definitions and uses | 13.3 | 0 | 1 |
| Factorial designs: an overview with applications to orthodontic clinical trials | 13.3 | 0 | 1 |
| Healthy Aging: Is Smaller Better? – A Mini-Review | 13.3 | 0 | 1 |
| Statistical issues for design and analysis of single-arm multi-stage phase II cancer clinical trials | 13.3 | 0 | 1 |
| The polypill as cardiovascular prophylactic: clinical trials | 13.3 | 0 | 1 |
| Challenges in Coding Adverse Events in Clinical Trials: A Systematic Review | 13.3 | 0 | 1 |
| Efficacy of memantine, donepezil, or their association in moderate-severe Alzheimer's disease: a review of clinical trials | 13.3 | 0 | 1 |
| Extracellular distribution of diffusible growth factors controlled by heparan sulfate proteoglycans during mammalian embryogenesis | 13.3 | 0 | 1 |
| Metabolic Correction in the Management of Diabetic Peripheral Neuropathy: Improving Clinical Results Beyond Symptom Control | 13.3 | 0 | 1 |
| The Use of Ginger (Zingiber officinale) for the Treatment of Pain: A Systematic Review of Clinical Trials | 13.3 | 0 | 1 |
| Growth factors, nutrient signaling, and cardiovascular aging | 13.3 | 0 | 1 |
| Allogeneic tumor cell vaccines: the promise and limitations in clinical trials | 13.3 | 0 | 1 |
| Incomplete reporting of recruitment information in clinical trials of biologic agents for the treatment of rheumatoid arthritis: A review | 13.3 | 0 | 1 |
| Efficacy and safety of ramosetron versus ondansetron for postoperative nausea and vomiting after general anesthesia: a meta-analysis of randomized clinical trials | 13.3 | 0 | 1 |
| Patient reported outcomes in rheumatoid arthritis clinical trials | 13.3 | 0 | 1 |
| Vascular endothelial growth factors (VEGFs) and stroke | 13.3 | 0 | 1 |
| Systematic Review for Effectiveness of Hyaluronic Acid in the Treatment of Severe Degenerative Joint Disease (DJD) of the Knee | 13.3 | 0 | 1 |
| State-of-the-Art management of knee osteoarthritis | 13.3 | 0 | 1 |
| Lipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: a systematic review and meta-analysis | 13.3 | 0 | 1 |
| Evidence-based medicine: the design and interpretation of noninferiority clinical trials in veterinary medicine | 13.3 | 0 | 1 |
| Coacervate delivery systems for proteins and small molecule drugs | 13.3 | 0 | 1 |
| Translating dosages from animal models to human clinical trials--revisiting body surface area scaling | 13.3 | 0 | 1 |
| Managing knee ostheoarthritis: efficacy of hyaluronic acid injections | 13.3 | 0 | 1 |
| Osteoarthritis Research Society International Initiative on Recommendations for Conducting Clinical Trials in Osteoarthritis: Overview | 13.3 | 0 | 1 |
| Gabapentin prophylaxis for postoperative nausea and vomiting in abdominal surgeries: a quantitative analysis of evidence from randomized controlled clinical trials | 13.3 | 0 | 1 |
| Ongoing clinical trials in intracerebral hemorrhage | 13.3 | 0 | 1 |
| From clinical trials to clinical practice: single-agent carfilzomib adverse events and their management in patients with relapsed and/or refractory multiple myeloma | 13.3 | 0 | 1 |
| Bioresorbable scaffolds: current evidence and ongoing clinical trials | 13.3 | 0 | 1 |
| Evidence that the strategy is more important than the agent to treat rheumatoid arthritis. Data from clinical trials of combinations of non-biologic DMARDs, with protocol-driven intensification of therapy for tight control or treat-to-target | 13.3 | 0 | 1 |
| Laparoscopic radical and partial nephrectomy: The clinical efficacy and acceptance of the techniques | 13.3 | 0 | 1 |
| Thirty years of prophylactic cranial irradiation in patients with small cell lung cancer: a meta-analysis of randomized clinical trials | 13.3 | 0 | 1 |
| Fornix as an imaging marker for episodic memory deficits in healthy aging and in various neurological disorders | 13.3 | 0 | 1 |
| Biodegradable polymer Biolimus-eluting stent (Nobori®) for the treatment of coronary artery lesions: review of concept and clinical results | 13.3 | 0 | 1 |
| Updates on mechanism of action and clinical efficacy of risedronate in osteoporosis | 13.3 | 0 | 1 |
| Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies | 13.3 | 0 | 1 |
| Heterologous ("nonspecific") and sex-differential effects of vaccines: epidemiology, clinical trials, and emerging immunologic mechanisms | 13.3 | 0 | 1 |
| Early phase clinical trials to identify optimal dosing and safety | 13.3 | 0 | 1 |
| An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials | 13.3 | 0 | 1 |
| Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes | 13.3 | 0 | 1 |
| Defining moderate asthma exacerbations in clinical trials based on ATS/ERS joint statement | 13.3 | 0 | 1 |
| Hyaluronic Acid and Wound Healing | 13.3 | 0 | 1 |
| Steering tumor progression through the transcriptional response to growth factors and stroma | 13.3 | 0 | 1 |
| Cytotoxic and targeted systemic therapy in advanced and recurrent cervical cancer: experience from clinical trials | 13.3 | 0 | 1 |
| Encapsulated islet transplantation: strategies and clinical trials | 13.3 | 0 | 1 |
| Hematopoietic growth factors: personalization of risks and benefits | 13.3 | 0 | 1 |
| Hyaluronic acid hydrogels for vocal fold wound healing | 13.3 | 0 | 1 |
| Handbook of neuroemergency clinical trials | 13.3 | 0 | 1 |
| Extracellular Hsp90 (eHsp90) as the actual target in clinical trials: intentionally or unintentionally | 13.3 | 0 | 1 |
| Use of lenalidomide in the management of relapsed or refractory multiple myeloma: expert recommendations in Korea | 13.3 | 0 | 1 |
| The effects of intravesical therapy with hyaluronic acid for painful bladder syndrome: Preliminary Chinese experience and systematic review | 13.3 | 0 | 1 |
| Next‐generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneity | 13.3 | 0 | 1 |
| Evidence for the selective reporting of analyses and discrepancies in clinical trials: a systematic review of cohort studies of clinical trials | 13.3 | 0 | 1 |
| Linked Clinical Trials – The Development of New Clinical Learning Studies in Parkinson's Disease Using Screening of Multiple Prospective New Treatments | 13.3 | 0 | 1 |
| Potential of D‐cycloserine in the treatment of behavioral and neuroinflammatory disorders in Parkinson's disease and studies that need to be performed before clinical trials | 13.3 | 0 | 1 |
| The impact of socioeconomic status on access to cancer clinical trials | 13.3 | 0 | 1 |
| Clinical Efficacy and Possible Applications of Genomics in Lung Cancer | 13.3 | 0 | 1 |
| Innovative Drugs to Treat Depression: Did Animal Models Fail to Be Predictive or Did Clinical Trials Fail to Detect Effects? | 13.3 | 0 | 1 |
| Evidence for Long-Term Use of Intramuscular Interferon Beta-1a: An Overview of Relapse, Disability, and MRI Data from Selected Clinical Trials | 13.3 | 0 | 1 |
| The role of skin care as an integral component in the management of acne vulgaris: part 1: the importance of cleanser and moisturizer ingredients, design, and product selection | 13.3 | 0 | 1 |
| On the proper use of the crossover design in clinical trials: part 18 of a series on evaluation of scientific publications | 13.3 | 0 | 1 |
| Phase I (first-in-man) prophylactic vaccine′s clinical trials: Selecting a clinical trial site | 13.3 | 0 | 1 |
| Insulin-Like Growth Factors in the Gastrointestinal Tract and Liver | 13.3 | 0 | 1 |
| Challenges and opportunities in designing clinical trials for neuromyelitis optica | 13.3 | 0 | 1 |
| Strategies for dealing with missing data in clinical trials: from design to analysis | 13.3 | 0 | 1 |
| Clinical Trials in Autosomal Dominant Polycystic Kidney Disease | 13.3 | 0 | 1 |
| Lost in translation: animal models and clinical trials in cancer treatment | 13.3 | 0 | 1 |
| Experimental therapies and ongoing clinical trials to slow down progression of ADPKD | 13.3 | 0 | 1 |
| The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials | 13.3 | 0 | 1 |
| Establishing equivalence or non-inferiority in clinical trials: part 20 of a series on evaluation of scientific publications | 13.3 | 0 | 1 |
| Magnetic resonance imaging striatal volumes: A biomarker for clinical trials in Huntington's disease | 13.3 | 0 | 1 |
| The past, present and future of stem cell clinical trials for ALS | 13.3 | 0 | 1 |
| Q27005551 | 13.3 | 0 | 1 |
| Epothilones: From Discovery to Clinical Trials | 13.3 | 0 | 1 |
| Growth Factors for the Treatment of Ischemic Brain Injury (Growth Factor Treatment) | 13.3 | 0 | 1 |
| Knowledge-based pharmcodynamics biomarkers implementation using commercially available databases in early-stage clinical trials | 13.3 | 0 | 1 |
| In search of evidence-based treatment for concussion: characteristics of current clinical trials | 13.3 | 0 | 1 |
| Authorship in a multicenter clinical trial: The Heart Failure—A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) Authorship and Publication (HAP) Scoring System Results | 13.3 | 0 | 1 |
| Liver Safety Assessment: Required Data Elements and Best Practices for Data Collection and Standardization in Clinical Trials | 13.3 | 0 | 1 |
| Capturing and Incorporating Patient-Reported Outcomes into Clinical Trials: Practical Considerations for Clinicians | 13.3 | 0 | 1 |
| AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION): 5-Year Update | 13.3 | 0 | 1 |
| Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials | 13.3 | 0 | 1 |
| Endpoints, patient selection, and biomarkers in the design of clinical trials for cancer vaccines | 13.3 | 0 | 1 |
| What we have learned: the impact of quality from a clinical trials perspective | 13.3 | 0 | 1 |
| Spinal cord injury neuroprotection and the promise of flexible adaptive clinical trials | 13.3 | 0 | 1 |
| Retracted: ‘Clinical trials in Alzheimer’s disease’: immunotherapy approaches | 13.3 | 0 | 1 |
| Treatment of endometriosis in different ethnic populations: a meta-analysis of two clinical trials | 13.3 | 0 | 1 |
| Multifaceted Role of Insulin-Like Growth Factors and Mammalian Target of Rapamycin in Skeletal Muscle | 13.3 | 0 | 1 |
| The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials | 13.3 | 0 | 1 |
| An overview of pain management: the clinical efficacy and value of treatment | 13.3 | 0 | 1 |
| Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD – mixed treatment comparisons of clinical efficacy | 13.3 | 0 | 1 |
| The totally extraperitoneal method versus Lichtenstein's technique for inguinal hernia repair: a systematic review with meta-analyses and trial sequential analyses of randomized clinical trials | 13.3 | 0 | 1 |
| Clinical application of adoptive T cell therapy in solid tumors | 13.3 | 0 | 1 |
| Recommendations for appropriate sublingual immunotherapy clinical trials | 13.3 | 0 | 1 |
| All about running: synaptic plasticity, growth factors and adult hippocampal neurogenesis | 13.3 | 0 | 1 |
| An individual patient-based meta-analysis of the effects of dronedarone in patients with atrial fibrillation | 13.3 | 0 | 1 |
| Bee venom acupuncture for rheumatoid arthritis: a systematic review of randomised clinical trials | 13.3 | 0 | 1 |
| Clinical trials of combined molecular targeted therapy and locoregional therapy in hepatocellular carcinoma: past, present, and future | 13.3 | 0 | 1 |
| The Search for Longevity and Healthy Aging Genes: Insights From Epidemiological Studies and Samples of Long-Lived Individuals | 13.3 | 0 | 1 |
| Easy-to-Read Informed Consent Forms for Hematopoietic Cell Transplantation Clinical Trials | 13.3 | 0 | 1 |
| Dendritic cell-based immunotherapy for glioma: multiple regimens and implications in clinical trials | 13.3 | 0 | 1 |
| Biomarkers in Cardiovascular Clinical Trials: Past, Present, Future | 13.3 | 0 | 1 |
| Pharmacokinetics, efficacy and safety profiles of etanercept monotherapy in Japanese patients with rheumatoid arthritis: review of seven clinical trials | 13.3 | 0 | 1 |
| Can medical therapy mimic the clinical efficacy or physiological effects of bariatric surgery? | 13.3 | 0 | 1 |
| Patient Selection in Heart Failure With Preserved Ejection Fraction Clinical Trials | 13.3 | 0 | 1 |
| Impact of baseline HIV‐1 RNA levels on initial highly active antiretroviral therapy outcome: a meta‐analysis of 12,370 patients in 21 clinical trials* | 13.3 | 0 | 1 |
| Drug Reaction, Skin Care, Skin Loss | 13.3 | 0 | 1 |
| Pharmacological perioperative brain neuroprotection: a qualitative review of randomized clinical trials | 13.3 | 0 | 1 |
| Reviews on recent clinical trials | 13.3 | 0 | 1 |
| Cryolipolysis for noninvasive body contouring: clinical efficacy and patient satisfaction | 13.3 | 0 | 1 |
| Practical clinical trials in psychopharmacology: a systematic review | 13.3 | 0 | 1 |
| γδ T cells for cancer immunotherapy: A systematic review of clinical trials | 13.3 | 0 | 1 |